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SYNOPSIS 
The work discussed in this thesis is in three parts. The 
initial work carried out was to develop a differential pulse 
polarographic Cd.p.p.) method .for the determination of Msodium 
cromoglycate CINTAL) in human urine sa~ples. The method eventually 
recommended involves an ion-pair extraction of the cromoglycate 
with tri-n-butylbenzylphosphonium chloride into chloroform. After 
evaporating the. chloroform, and dissolvine the residue in a buffer· 
solution, down to 0.5 ~g INTAL per ml urine Can be determined. 
The method has the distinct advantages of simplicity and speed 
over the colorimetric method currently in use. 
Colorimetric and d.p.p. methods were developed for the 
determination of sulphaguanidine after derivatization with 
hypochlorite and phenol. The methods are reasonably selective 
for sulphaguanidine, and could be applied advantageously for 
identification as well as determination. Good precision was 
obtained when the reaction conditions were properly controlled, 
so that, the procedure may be of value even though the clinical 
use of sUlphaguanidine is declining. 
The main work has been concerned with a d.p.p. polarographic 
study of several cephalosporins and their degradation products. 
D.p. polarographic methods were developed for the determination of 
eight cephalosporins in aqueous buffer soluti0lls. The potentialities 
of d.p.p. for studying the degradation of cephalosporins has been 
1 
illustrated. ,In particular the evolution of hydrogen sulphide has 
been noted during the degradation of cephalexin and cephradine, 
and this hydrogen sulphide has been determined by an indirect d.p.p. 
method. Polarographic reduction peaks due to other degradation 
products have been ~dentified. The reports of previous workers on 
non-polarographic methods have been confirmed, and it is now possil,le 
to follow the formation and degradation of several degradation 
products polarographically. The concentration of several products 
can now be determined for the first time. 
On the basis of our degradation studies, an indirect d.p. 
polarographic procedure has been developed for the determination of 
cephalexin after hydrolysis in pI! 7.4 phosphate buffer solution at 
1000 C for 1 hour. The recommended procedure has been shown to be 
superior to two other d.p.p. procedures developed and assessed in 
the present study. Also the sensitivity of this method is much 
better than d.c. and cathode-ray polarographic procedures developed 
by other ''Iorkers. 
Final stUdies have been made on the degradation of ampicillin 
(a penicillin of similar structure to cephalexin). Hydrogen 
" sulphide was found not to be formed during the degradati on, and the 
two major degradation products at pH 2.5 observed polarographically 
were penicillamine and 2-hydroxy-3-phenyl-6-methylpyrazine. D.p.p. 
procedures for the determination of these products have been developed, 
and the amounts of penicillamine and 2-hydroxy-3-phenyl-6-methylpyrazine 
,have been determined in degradation solutions of ampicillin. 
2 
GENERAL INTRODUCTION 
Direct current polarographic analysis was introduced in 1922 
by Professor J. Heyrovsky1 Polarography is defined as a method 
making use of current-potenti~ curves obtained in the electrolysis 
at a dropping mercury electrode (d.m.e.) of the solution to be 
analysed. Later, the application of solid electrodes2 , which may 
be stationary, rotated or vibrated, was introduced. Polarography 
with solid electrodes is often called voltammetry. 
Polarography derives its analytical importance from two 
characteristics of current-potential curves. First, the half~ 
wave potential (the potential at which the current is one-half 
the diffusion value) may indicate the identity of the sUbstance 
which undergoes electron transfer. Second, the magnitude of 
the diffusion current is governed by the concentration of the 
electroactive substance. 
In d.c. polarography, a very slow moving d.c. potential ramp 
is applied to the dropping mercury electrode. As the potential 
of the electrode moves into a region in which an electrode reaction 
takes place, a current is obtained, and the characteristic S-shaped 
polarographic ~ave is developed. However, d.c. polarography is 
not satisfactory at concentrations below about 10-5M. This is 
because at such low concentrations, the faradaic current, caused 
by the reduction of the electroactive species, is reduced to the 
same order of magnitude as the charging current (current required 
to charge the electrode double layer). Further, the resolution 
.' 
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becomes very poor in the presence of relatively large concentrations 
of more easily reduced substance. In order to improve the sensitivity 
and the resolution, a number of variations on d.c. polarography have' 
been introduced3• Pulse polarography which was first introduced 
by Barker in 19604 can be ccnsi.dered as one of the best of these 
variations • .Recently, a number ofpub,lications which riiscuss the 
theory and application of pulse polarography have t- -10. appeared;> 
Two pulse polarographic techniques are in general use; normal 
(or integral) pulse polarography (n.p.p.) and differential pulse 
polarography (d.p.p). In normal pulse polarography, potential 
pulses of successively increasing amplitude from a fixed initial 
potential are applied to the working electrode at a fixed time during 
4 
the drop life or during the timing period (for a stationary electrode). 
The pulses are usually 50-60 msec in duration and the current is 
measured (sampled) at some fixed time, (usually 40 msec) after pulse 
application. The time between pulses is usually 0.5 to 5 sec, and 
sample and hold circuits are utilized to display the sampled current 
on a conventional recorder11 • The potential waveform and the 
resulting current-time behaviour for normal pulse polarography are 
shown in Fig. 1. The timing of the pulse application is such that 
it is applied to the electrode for 50-6Omsec before the drop is 
dislodged by a mechanical drop timer in the case of d.m.e. or 
50-60 msee before the timing sequence ends when Cl stationary electrode 
is used. Therefore, when a d.m.e. is used the pulse is applied 
to>1ards the end of the drop life ,~hen the rate of change of the drop 
area dA/dt is small and the electrode may be considered as a 
stationary electrode. 
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There are two sources of current resulting from pulse 
application: the faradaic current If and the capacitance current 
I. The capacitance current decays exponentially, while the c 
faradaic current decays at a much 1(l1ower rate. In potential 
regions where a faradaic current is present, the measured current' 
is the sum of Ic + If' Examination of Fig. 1 shows that 
after If{) msec of pulse application, the capacitance current I 
c 
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is decayed to a negligible value compared with the faradaic currcnt. 
Thus the measured current, is more nearly a pure faradaic current 
than is the case with d.c. polarography. 
The normal pulse polarographic current on the diffusion plateau 
is given by Cottrell equation12• 
1 1 
= n F A n-2c I 6rt)2 ••••••••••••••• · ••••••••••• (1) 
where id is the normal pulse current in microamperes, 
(n.p.p.) 
n the number of electron involved in the reduction or 
oxidation of the electroactive species, 
the Faraday (96500 coulomb/equivalent), 
the electrode area in cm2, 
F 
A 
D 
C 
t 
2 the diffusion coefficient of the reacting species in cm /sec, 
the bulk concentration in mM, 
the time in seconds measured from pulse application, 
at which the current is measured. 
substituting the area term A for the 
factor (t)~ of the Ilkovic equation, 
462 nD~Cm-1t 1-
growing drop and including the 
equatrDn 1 becomes 
d i( ) = ~ ••••••••••••••.•••••••••••• (2) 
n.p.p. t" 
A = (4rr f1 (3 x lO-3/(L )-1 m1-t 1-
!!g d 
where '1Ig is 13.534 g/cm3 at 250C, m is the mercury flow rate mg/sec 
and td is the drop time in sec • 
.. 
The sensitivity of normal p\llse polarography with respect 
to d.c. polarography can be obtained by calculatin~ the ratio of 
the normal pulse current'i( from equation (2) and the d.c. 
n.p.p 
current obtained from Ilkovic equation (3) 
1 
462 nD~C mt t! •••••••.••.•••.•••.••• • (3) 
i(n.p.p.) = 
i(d.c.) 
-1 3 t 2 (7f-) •••.••• ' •••••••••.••••••••••••••• (4) 
For reasonable values of td and t the ratio i( )/i(d) n.p.p .c. 
lies in the range 3-6 (Ref. 10). It follows that the analytical 
signal in pulse polarography is larger than that in classical 
d.c. polarography by a factor of 3-6. In practice, 
however, pulse polarography is more sensitive than it is predicted 
from equation 4. This additional increase in sensitivity arises 
from the ability of the technique to discriminate against the 
capacitance current and yield a signal composed mainly of the 
faradaic component which can be amplified11 • 
In differe!1tial pulse polarography, a linearly increasing 
d.c. potential ramp is applied to'the working electrode and a fixed- . 
.. height potential pulse is superimposed near the end of the life 
of each drop or at the end of the timing period (for a stationary 
electrode) • The current is sampled twice during the life of .each 
mercury drop (or twice during the timing period in the case of 
stationary electrode). In the Model PAR 174 which has been used 
throughout this study, the current is measured (averaged) for 16.7 
msec just prior to pulse application and again for the Same period 
7 
-I 
I 
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starting 40 maee· after the pulse has been applied. Zero difference 
is obtained when the currents are equal. Therefore, only at or 
near a half-wave potential is there a difference in the current 
flowing before and after the p~lse application. This will give 
rise to a peaked representation of the data (see Fig. 2 and 3). 
The relation between the peak current in differential pulse 
polarography i(d ) and the normal pulse current i( ) 
.p.p n.p.p. 
is given by equation 5 
= (a -1)/(a + 1) ••••••••• (5) 
where a' = exp (-[LE/2)nFIRT,b E is the pulse amplitude, in mV 
and other terms are as previously defined. 
The ratio (a -.1 )/( a + 1) depends only on the pulse amplitude 
bE and the number of electrons n transferred during the electro-
chemical reaction. This ratio is always less than one. 
The pulse amplitude has a remarkable effect on the d.p.p. 
current. For small pulse amplitude the d.p.p. current increases 
roughly linearly with bE, and therefore an increaGe in bE gives better 
sensitivity, however, at v~ry large values of bE the problem of 
capacitance current becomes worse, 
, In n.p.p. the current increases linearly with n while in d.p.p. 
the current increases linearly with n2 for a small pulse amplitude. 
Therefore, for compounds in which,the number of electrons involved 
in the electrochemical reaction is large, higher sensitivity is 
.' 
obtained than is the case with n.p.p. 
The relation between peak potential," Ep, and half-"ave potential 
·is given by the relation 
E 
P = 
&. 
2 ••••••••.•• _ .••••••.•.•••••••••• (6) 
For a very small pulse amplitude for a reversible system E =E,. 
P '2 
The peak half-width which is a measure of the resolution is 
dependent on the pulse amplitude and the number of electron involved. 
For a large.a.E, (Ca. liE> 75 mV) as .lIE increased, the peak "idth 
increases, but at small 6E, the peak half-width is independent of 
. pulse amplitude and inversely proportional to the number of electrons 
10 transferred • 
The above relationships have been derived for a reversible 
elect'I'ochemical reactions and will not necessarily hold for 
irreversible cases. It is important therefore, to select the 
experimental conditions carefully to maximize the reversibility of 
the system by judicious selection of the supporting electrolyte. 
The faradaic current in differential pulse polarography is 
less than that of normal pulse polarography. Nevertheless, the 
detection limit in d.p.p. is lower than that of n.p.p.. This can 
be attributed to a number of factors. In normal pulse polarography 
each pulse has a greater amplitude than the previous one and during 
the course of the scan the pulses become quite large, which results 
in a large capacitance current. The capacitance current in 
differential pulse polarography, however, is considerably less than 
.. 
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that for normal pulse polarography owing to the pulse amplitude being 
small and uniform, and the resulting current which is relatively 
noise-free is more amenable to signal processing i.e. amplification. 
Further, differential pulse polarography provides peaks, which are 
more easily measurable specially at low concentrations, instead of 
steps as in the case of normal pulse polarography. Thus at high 
concentrations the limiting current obtained by normal pulse 
polarography'will be larger than the peak current obtained by 
differential pulse polarography, but the limit of detection by 
differential pulse polarography will be considerably less than 
by normal pulse polarography (see Fig. 3). 
Polarographic analysis has been used frequently in studying 
compounds of pharmaceutical importance in the 1950's. Brezina and 
Zuman13 Volke14 and Zuman15 surveyed the polarographic behaviour 
and assays of the active constituents of many pharmaceutical 
preparations in addition to reviewing the application of the 
technique to biochemistry and medicine. The decreased interest 
in the application of d.c. polarography during the 1960's and the 
beginning of this decade, particularly for drug analysis, can be 
attributed to a number of factors: 
1. The low sensitivity and poor resolution of d.c. polarography 
2. Increased analytical requirements for trace analysis to provide 
evidence of purity (in environmental, food and drug analysis). 
3. Development of more potent drugs administered in smaller amounts 
and the tendency for smaller sample size to be available 
(particularly when blood samples are involved). 
12 
4. Emergence of other sensitive instrumental techniques with 
the desired sensitivity and resolution such as gas-liquid 
chromatography. 
5. Increase in the number of samples and the need for manpower 
economy. 
During the present decade, increasing interest has been shown 
in the application of polarography and other voltammetric techniques 
of analysis of organic compounds especially drug compounds. This 
interest has been brought about mainly by the development of pulse 
polarograPhy4 together with the commercial availability of reliable 
but relatively simple and inexpensive instruments. Moreover, in 
more recent developments, commercial automatic polarographic 
analysers such as PAR Model 374 and PAR Model 384-1 were introduced. 
These instruments incorporate a pressurised mercury electrode in an 
automatic system, and also contain a microprocessor unit which is 
capable of subtracting a pre-recorded blank. These developments 
have extended into the region of trace analysis the lower limit 
of the range of concentrations over which polarography can be applied. 
Also, it allows the analysis of large numbers of samples both in 
pharmaceutical control and in production. 
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Advantages and limitations of pulse polarography 
Polarography and particularly its more sensitive extension, 
differential pulse polarography of the analysis of pharmaceutical 
have several distinct advanta&es which can be summarised as follows: 
1. Although large numbers of organic compounds of pharmaceutical 
importance are polarographically active, and can be 
determined directly by polarography, other electroinactive 
compounds can be made amenable to polarography after simple 
deri vatization. 
2. The sensitivity and resolution of the technique is sufficiently 
high to enable the determination of small amounts of 
polarographically active drug compound or traces of impurities 
or·degradation products. 
3. Polarography is a "cold" method of analysis which permits the 
drug compound of interest to be recovered and subjected to 
further analytical procedures. 
4. Pharmaceutical preparations can in many cases be analysed 
without separation of the excipients. Also the technique is 
applicable to the analysis of turbid and coloured.solutions. 
5. One of the attractive features of polarography is that as we 
usually record the whole polarogram, any carelessness in handling 
the electrode, the hydrolysis cell or the presence of any 
electroact~ve interfering species will be noticed by the 
formation of new polarographic waves or the deformation in the 
wave shape. In contrast, in other techniques such as colorimetry, 
14 
15 
DV spectrophotometry and spectrofluorimetry the common 
practice is not to record the whole spectra, but to carry out 
the measurements over ranges of few nanometres. The 
numerical values in this case neither indicate the presence 
of any interfering absorbing substance, nor it shows how 
carefully the analysis was carried out. 
Differential pulse polarography also has some limitations. 
In many organic reductions the size of the peak currents (i ) in 
. p 
d.p.p. is governed by the rate at which the current increases when 
the potential pulse is applied. For this reason the peak current 
is highly dependent on the exact composition of the matrix in which 
the polarography is carried out. A slight change in matrix 
composition can alter the peak current considerably. 
Another problem is the nature of the capacitance background in 
d.p.p., which has the form of a differential capacitance curve. 
Adsorption of compounds from the solution alters the double layer 
.capacitance and will increase the capacitance background in particular 
potential regions. The presence of traces of surface active materials· 
can produce spurious capacitance peaks and/or enhance faradaic peak 
currents. This will normally only be apparent at high sensitivities. 
Differential pulse polarography has recently been successfully 
applied to the analysis of drug compounds in biological fluids, 
formulations and dosage forms. The technique was applied either 
directly for drug compounds which have an intrinsic polarographic 
activity or after derivatization for those which do not show any 
polarographic activity. The number of publications dealing with these. 
applications is steadily increasing. The aim of the present discussion 
is not to survey these publications, but to point out the potentialities 
of d.p.p. in stUdying drug comrounds guided by a selection of some 
important examples. The application of polarography and other 
voltammetric techniques to the analysis of organic compo'lnds of 
. . '. 16-20 pharmaceutl.cal l.mportance has been revl.ewed elGewhere • 
The work of Brooks ~18 adequately illustrates the usefulness 
of differential pulse polarography in the analysis of drug compoul\ds 
and their metabolites in biological fluids, and will be discussed 
in Bome detail. 
Brooks et al developed adirect d.p.p. procedure for the 
determination of two N-1-substituted nitroimidazoles, several 
benzodiazepines "diazepam(Valium), chlorodiazcpoxide hydrochloride 
(Librium) and nitrazepam (Mogadon)" and trimethoprim and its 
metabolites in blood. Also they employed an indirect d.p.p. procedure 
to assay phenobarbital, diphenylhydantoin and glibornuride. 
As with other methods of analysis, it was necessary to 
··separate the drug Gpecies of interest prior to the determination step. 
The direct differential pulse polarographic procedures for the 
, 
determination of the first group of drug compounds requires obtaining 
a protein free filtrate of blood with 10% sodium tungstate in 10% 
sulphuric acid, followed by extractil\g the drug into an organic solvent 
and dissolving the residue after evaporating the solvent into a 
suitable supporting electrolyte for polarography. The sensiti.vity of 
17 
the asaay for both 1I-1-aubsti tuted ni troi,.idazolc is about 0.2 - 0.3w; 
per ml blood, with a r,~covery of approldmately 50%. 
In the case of diazepam, t:,e extraction proc"dure was not specific 
enough as the desmethyl metabolite"is also co-extracted and interferes 
in the polarography. Therefore, the authors found it necessary to 
separate the parent compound from its metabolite by thin layer-
chromatography. The spots were eluted with ethanol, and the 
residues of . which were analysed by d.p.p. after dissolving in a 
suitable supporting electrolyte. Similar procedures were used for 
the determination of Librium, }logadon and their metabolites in blood 
samples. The procedure which ~las developed for the determination of 
trimethoprim employs selective extraction of the drug into chloroform 
from blood or urine. For the assay of blood, the drug was back-
extracted into sulphuric acid and analysed directly by d.p.p. 
Urinary trimethoprim was first separated by t.l.c. from its 
l'1etabolites, eluted with ethanol, and the residue of which >las 
dissolved in sulphuric acid for polarography. 
Brooks et al successfully determined phenobarbital, 
diphenylhydantoin and glibornuride by indirect differential pulse 
.. polarographic procedures. The assay involves selective extraction 
of the drug compound into an organic solvent from whole blood, 
follo'Ning sui table "clean-up" of the sample. Each compound. wan 
nitrated in 10% KNOy'H2SO/+ at 25°C for 1 hour. The nitroderivatives 
were extracted into a suitable organic solvent ruId the residues 
were dissolved in the supporting electrolyte for polarography. The 
d •. p.p. assay of the nitrod.erivatives of phenobarbital and 
diphenylhydantoin enabled these compounds to be determined with a 
sensitivity of 1~2 ~g per ml blood, while a sensitivity of 0.1 - 0.2 ~g 
per ml of blood was obtained for the assay of glibornuride. 
D.p.p. have also found application in the determination of drug 
compounds in formulations. The degree of prior separation required, 
depends upon the other ingredients present. In some cases simple 
dissolution is sufficient. In others some form of clean-up is 
required prior to the determination steps. This is illustrated in 
the following examples. Oelschlager et a121 'developed d.c. and d'.p.p. 
procedures for the determination of chlordiazepoxide (Librium) in 
ten different commercial formulations, without the need for initial 
separation from other drugs or excipients., Teare et al in 197822\, 
developed a d.p.p. procedure for the determination of flucytosine 
in tablets. The drug compound was first extracted from tablets with 
aqueous hydrochloric acid solution before it was polarographed 
in phosphate buffer. 
The introduction of solid electrodes such as glassy carbon, 
carbon paste, rotating platinum and silicon rubber based graphite 
electrodes to the analysis of drug compounds has made volta~metry 
applicable to a very wide range of drug compounds. Thus many drug 
compounds which have no reducible functional groups, may be determined 
by an oxidation process at an indicator electrode, either in aqueous 
or non-aqueous solutions. 
The glassy carbon electrode is now being extensively used in 
flowing systems for flow-injection analysis and as a detector in 
HPLC systems23• 
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DIFFERENTIAL PULSE POLAR03RAPHIC DETERHINATION OF 
DISODIUM CRQ.I03LYCATE (DSCG) IN URINE 
Introduction 
Intal is the trade name of disodium cromoglycate (DSCG) 
(the disodium salt of 1,3-di(2-carboxy-4-oxychromen-5-yloxy) 
, 
pr~pan-2-0i) 1• DSCG, is freely soluble in water up to 5% and has a 
molecular weight of 512.3 
NaOOC COONa 
DISODIUM CROMOGLYCATE 
DSCG represents a new pharmacologic approach to the treatment 
of bronchial asthma. The compound is poorly absorbed from the 
gastro-intestinal tract after oral administration, but after inhalation 
as a fine powder into the lungs - using a special inhalation device -
the compound is well absorbed and rapidly eliminated unchanged in 
the urine and bile2 • The absorption, distribution and excretion 
characteristics in a number of laboratory animals have been 
3-4 reported • 
Analytical methods developed for the determination of DSCG in 
absorption and metabolic studies include a fluorimetric method for 
its determination in Plasma2, and a colorimetric method for its 
determination in urine2,5. The intrinsic fluorescence properties 
of DSCG in aqueous solutions of pH greater than 2 has been made the 
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basis of the fluorimetric method. The method was applied after a 
preliminary purification of the plasma to remove naturally occurring 
fluorescent substances which interfere with the measurements. The 
clean-up process included precipitation of the plasma protein 
followed by extraction of DSCG into ethyl acetate. The DSCG was 
then back-extracted into dilute a~monia solution, and concentrated 
to a small volume under vacuum. The sample was then applied to a 
silica gel TLC plate. The DSCG was eluted from the plate with 
potassium dihydrogen phosphate solution and the fluorescence of the 
centrifuged supernatent layer was measured at an excitation wavelength 
of 350nm and an emission wavelength of 450nm. 
In the case of urine samples, interfering substances present in 
urine caused a lack of specificity and precluded the use of the above 
method for measurement of DSCG. However, a colorimetric method 
for DSCG determination in urine based on the instability of the 
chromone ring to alkali has been developed2• The method involves 
the alkaline hydrolysis of DSCG to bis-o-hydroxyacetophenone, which is 
then reacted with diaiotised p-nitroaniline to form an azo compound, 
having an absorption maximum of 490nm. The clean-up ste~ preceding 
the cOlorimetric determination included passing the urine sample 
after acidification with formic acid (98-100'fo) through a column 
of Amberlite ion-exchange resin. Most urinary constituents, but 
not DSCG, come through the column on washing with aqueous formic acid, 
DSCG is later eluted with 98% formic acid and the residue after 
evaporating the eluate is subjected to the hydrolysis process. Curry 
and Mil1s5 reported that, in order to obtain the recovery, precision 
and accuracy reported by Moss, G~F., et a12 , they found it necessary 
22 
to use a radioactive internal standard. 
The aim of the present study was to develop a sensitive, 
precise and rapid polarographic method to determine DSCG in urine 
samples to replace the time consuming colorimetric method currently 
in use. 
In the present work, the polarography of DSCG has been studied, 
and a differential pulse polarographic method for the determination 
of DSCG.tn urine has been developed. Separation of DSCG from urine 
can be effected either by extraction of cromoglycic acid from acidic 
solution into ethyl acetate, or by extraction of di-(tri-n-butyl-
benzylphosphonium) cromoglycate from aqueous solution, over a wide 
pH range into chloroform. In both cases the organic solvent is 
evaporated and the DSCG is dissolved in a suitable supporting 
electrolyte for polarography. 
Experimental 
Equipment. Polarographic measurements were made with a PAR 174 
polarographic analyser (Princeton Applied Research Corporation), 
equipped with a drop timer. Polarograms were recorded with an 
Advance HR 2000 x-y recorder. Three electrode operation was used 
with a dropping mercury electrode as working electrode, a platinum 
counter electrode and a saturated calomel reference electrode. 
For differential pulse operation, the forced drop time was 0.5 second, 
-1 the pulse height 50mV and the scan rate 5 mV s ,except where 
otherwise indicated. The dropping mercury electrode used had (at 
an open circuit) a flow rate of 1.76 mg s~1 and a drop time of 3.5 
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sec. in B.R. buffer solution·pH 6 at a mercury reservoir height of 
68cm. Traces of oxygen in the nitrogen gas used to deoxygenate the 
6 
solutions were removed by means of vanadium(II) scrubber • 
Spectrophotometric measurements were made with Pye Unicam SP 8000 
and SP 600 spectrophotometers. 
Reagents. All chemicals were of analytical reagent grade except 
where otherwise stated. 
Disodium cromoglycate. A pure sample of DSCG, obtained from 
Fisons Pharmaceutical Ltd., was dried at 1000 C in a v~cuum oven to a 
constant weight before use. 
Tri-n-butylbenzylphosphonium chloride. Prepare 0.2M stock solution 
of tri-n-butylbenzylphosphonium chloride (Haybridge Chemical Co. Ltd) 
by dissolving 15.712g in 250ml distilled water. 
Britton-Robinson buffer solution. A stock B.R. buffer solution 
(pH 1.9) which is 0.0414 in boric acid, orthophosphoric acid and 
glacial acetic acid was prepared. From this stock solution, buffer 
solutions of varying pH were prepared by the addition of 0.2M sodium 
hydroxide solution and the pH was measured using a glass electrode 
connected to an expanded scale pH meter. Distilled methyl alcohol, 
butan-l-ol (S.L.R), chloroform, ethyl acetate, sodium perchlorate 
solution (0.414) and hydrochloric acid solution (2M). 
Experimental Technique 
Polarography of DSCG in aqueous solutions. 
(1) Study of the effect of pH on peak current and peak potentials 
Polarographic behaviour of DSCG in the pH range 2-12 was 
studied in B.R. buffer solutions. At pH values lower than 2, 
hydrochloric acid solutions were used. For each polarographic 
run, 1 ml of DSCG stock solution (1 x 10-1M) was pipetted into a 
10-ml calibrated flask, and then diluted to the mark with B.R. 
buffer of the required pH. After thorough mixing, the solution was 
placed in the polarographic cell, and deoxygenated with oxygen-free 
nitrogen for 10 minutes. The solution was blanketed by an atmosphere 
of nitrogen whilst the polarograms were recorded. Polarograms in 
d.p. and d.c. modes were obtained for each solution between 0.0 -
"';1.6v. 
\ 
(2) Effect of mercury reservoir height on the limiting ~urrent. 
DSCG stock soiution (lml, 10-1M) was diluted to volume in a 
10ml calibrated flask with B.R. buffer pH 6.0, mixed thoroughly, and 
transferred to the polarographic cell. After deoxygenation for 10 
min,d.c. polarograms were obtained at various mercury reservoir 
heights. 
(3) Coneentration Effect. 
The effecto.f concentration was studied in B.R. buffer solutions 
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pH 5.80 containing 10'fo methanol in the range 0.04 - 2.14 ~g/ml DSCG. 
Determination of DSCG in human urine 
The presence of naturally occurring electroactive constituents 
in the urine necessitated the separation of DSCG from urine before 
the polarographic determination step. Two approaches were found 
satisfactory for the separation of DSCG from aqueous standards and 
urine samples: 
(A) Ion-pair extraction of DSCG into chloroform 
Procedure. Into a clean, dry 35ml glass-stoppered centrifuge 
tube, place 2ml of urine sample spiked with DSCG and 5ml of n-butanol. 
Shake the tube gently for 30 seconds and then centrifuge for 
3 min at 2000 r.p.m. Carefully discard the (upper) organic layer 
with a syringe equipped l;ith a 6in. cannula. To the aqueous layer 
in the centrifuge tube, add lml of B.R. buffer solution (pH 1.9), 
2ml of aqueous 0.2f1 of tri-n-butylbenzylphosphonium chloride and 5ml 
of chloroform. Shake the tube gently for 30 seconds and centrifuge 
for 4 minutes at 4000 r.p.m. Carefully transfer the (lower) 
chloroform layer by means of a syringe to a 35ml glass centrifuge 
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tube. (In order to ensure that only chloroform is drawn into the syringe, 
draw a small amount of air into the syringe before passing the cannula 
through the aqueous layer. This air is then expelled when the tip 
of the cannula is in the chloroform, thus discharging any of the 
aqueous phase that has entered it). Re-extract the aqueous layer 
with a second 5ml portion of chloroform in the Same way. Evaporate 
the combined chloroform extracts to dryness in a water-bath under a 
stream of nitrogen. Dissolve the residue in 0.5ml of methanol and 
then add 4.5ml of B.R. buffer (pH 5.8).' Transfer the solution to 
the polarographic cell, deoxygenate it with oxygen free nitrogen for 
10 minutes, and obtain a differential pulse polarogram bet,~een -0.6 
and -l.OV. Another approach to recover DSCG from the chloroform 
layer was found to be satisfactory. This involves the back-extraction 
of DSoo from the chloroform layer into Zml of aqueous sodium 
perchlorate solution (0.4M). Add 3ml of B.R. buffer solution 
(pH 5.8) to the aqueous extract. Deoxygenate the solution and 
obtain a d.p. polarogram. 
Effect of tri-n-butylbenzylphosphonium chloride concentration on 
the differential pulse peak heights. 
B.R. buffer (4.5ml, pH 5.8), 0.5ml of methanol, and 0.1 ml 
of DSCG standard solution (100 ~g/ml) were pipetted into the 
polarographic cell. After deoxygenating the solution for 5 
minutes, a differential pulse polarogram was obtained. The above 
experiment was repeated using the same concentrations of DSCG and 
methanol in the presence of different concentrations of the 
phosphonium salt. 
Spectrophotometric determination of tri-n-butylbenzylphosphonium 
chloride co-extracted with DSCG. 
Aqueous solutions of the phosphonium salt show three absorption 
bands with A at 253nm, 258nm and 265nm. max However, the strongest 
absorption band at 258nm was used for the determination of the 
phosphonium salt in aqueous solutions. 
Standard solutions of the phosphonium salt in distilled water 
were prepared in the concentration range 1 x 10-3M - 2 x 10-2M• 
The absorbances of the standard solutions were measured against water 
as a reference at A max 258nm using a Unicam SP 600 spectrophotometer 
and 1 cm silica cell. 
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In each of four 35ml glass-stoppered centrifuge tubes, 2ml 
distilled water, lml of B.R. buffer solution pH 1.9, O.lml of DSCG 
standard solution (100 jJg/ml), 2ml of the phosphonium salt (0.2M) and 
5ml of chloroform were added. The contents were shaken for 30 
seconds, centrifuged for 4 minutes at 4000 r.p.m. and the organic 
layers were discarded. The aqueous layers were re-extracted with 
another 5ml portion of chloroform as above, and again the organic 
layers were discarded. The absorbance of the aqueous layers was then 
measured at 258nm using a 0.5cm silica cell against water as reference. 
The amount of phosphonium salt left in the aqueous layer was 
determined by comparing the absorbance with those of standards. 
(B) Procedure with ethyl acetate 
Place 2ml of urine sample and 5ml of ethyl acetate in a clean, 
dry 35-ml centrifuge tube. Shake gently for 30 seconds, carefully 
. remove (by syringe) the (upper) ethyl acetate layer and discard it. 
Repeat the above extraction using another 5ml portion of ethyl acetate. 
To the aqueous layer add 2ml hydrochloric acid solution (~1), and 
extract ,dth two 5-ml portions of ethyl acetate. Evaporate the combined 
ethyl acetate extract to dryness. Dissolve the ,'!'esidue in 0.5ml 
methanol and 4.5ml B.R. buffer solution pH 3.4 and obtain a d.p. 
polarogram as indicated above. (Alternatively, in this case, the 
DSCG may be back-extracted into 2ml of sodium hydroxide (2M), add 
3ml B.R. buffer pH 1.9. deoxygenate for 5 minutes, and record the 
. polarogram) • 
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Results and Discussion 
Pure DSCG was examined in B.R. buffer solution as the supporting 
electrolyte. The peak potentials and peak currents of the differential 
. -4 pulse polarographic peaks obtained for.allO M solution of DSCG in 
B.R. buffer solutions at various pH values are shown in Table 1 and 
Figure 1. 
Table 1. 
pH 
0.4 
0·7 
1.1 
1.7 
3·0 
4.0 
5·0 
6.0 
7·0 
8.0 
9.0 
10.0 
11.0 
12.0 
Effect of pH on the peak potep.tials and peak currents of 
d.p.p. peaks obtained for 10-~ solution of DSCG in B.R. 
buffer. 
Peak 1 Peak 2 Peak 3 Peak 4 
-E (v) p i/)lA -Ep(V) i/)lA -Ep(V) i/)lA -E (v) p i/rA 
0.53 3.1 0.83 1.30 
0.58 2.4 0.87 1.50 
0.61 2.2 0.90 1.50 
0.63 2.3 0.92 1.50 
0.70 1.9 1.0 0.80 
0.78 1.9 1.1 0.10 
0.88 2.1 1.18 0.10 
0.96 3·5 
1.02 4.0 
1.10 3.1 1.lKJ 0.20 1.60 0·35 
1.17 2·3 1.37 0.70 1.60 0.70 
1.20 0.5 1.35- 1.20 1.60 0.95 
1.35 1.40 1.60 0.80 
1.35 1.50 1.62 0.60 
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Fig. 1. Effect of pH on the peak potentia1s a~~ peak currents 
of the d.p.p. peaks obtained for a 10 M solution of 
DSCG in B.R. buffer. Full lines, peak potentials 
vs pH; broken lines, peak currents vs. pH • 
• 
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The peak potential of the main (first) peak is (-0.47 - 0.078 pH)v 
in the pH range 2-9; the change of the peak potential with pH is 
consistent with an irreversible electrode reaction. The size of 
the main (first) peak is clearly dependent on pH and is at a maximum 
at pH 7. 
The effect of mercury reservoir height on the limiting current 
of the main waYe is shown in Figure 2. The plot of wave height versus 
the square root of the height h of the mercury column (measured between 
the level of mercury in the reservoir and the tip of capillary) 
which is corrected for the interfacial tension at the surface of the 
growing drops (~ack) gave a straight line passing through the origin 
indicating diffusion control. 
hcorr = h - ~ack' 
where m is mercury flow rate (mg/sec), and t is the drop time. 
Knoboch,E? has studied the electroreduction of chromone compounds 
in citrate-bydrochloric acid buffer solutions, and showed that these 
compounds are reduced irreversibly at the dropping mercury electrode. 
The reduction process which occurs at the 'c = 0 group in position 4 
involves a two electron reduction step according to the following 
schemes: 
OH 
+ + e-+H -
-
R 
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Fig. 2. Effect of mercury reservoir height (h) on the limiting current of the main d.c. 
polarographic wave. Mercury reservoir hiehgt Ch): (1) 76, (2) 60, (3) 52, (4) 44cm. 
In addition to the reduction wave, a catalytic wave 
accompanied by an adsorption pre-wave observed in buffer solution 
at pH values lower than 4. The catalytic wave was pH dependent 
and increased in size with increasing pH. However, both w.aves 
disappeared in the presence of surfactants. 
DSOO, which contains two substituted chromone rings, undergoes 
• 
electroreduction at the dropping· mercury electrode. Two 
polarographic reduction waves were obtained· in B.R. buffer solution 
at pH values lower than 5. The peak current of the second wave 
is strongly dependent on pH, and decreases in size considerably 
as the pH is increased; it reached about 6% of its maximum size 
at pH 4 •. However, buffers which also contained glycine and citric 
acid gave an adsorption wave between the two waves obtained for 
DSCG in B.R. buffer in the pH range 2 - 5. This wave disappeared 
when the DSOO concentration was reduced to'~ 10-4M• This effect 
is shown in Fig. 3. 
From the above information, it seems to be that DSCG follo~m 
the same polarographic behaviour of chromone compounds studied 
by Knoboch, E7. 
~ical d.p. polarograms obtained for DSOO in B.R. buffer 
solution (pH 5.8) containing 10'fo methanol are shown in Fig. 4. 
A rectilinear calibration curve was obtained in the concentration 
range 0.04 - 2.14 ~g/ml and is shown in Fig. 5. 
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Fig. 3. Effect of DSCG concentration on the second d.p.p. peak of DSCG obtained 
in a buffer solution containing citric acid, orthophosphoric acid, 
hydrochlorip' acid, and gl~cine, (pH 2.3). DSCG concentration: 
(a) 1 x 10-'"'M Cb) 1 x lO-::>M . 
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Fig. 4. Typical d.p. polarograms obtained in B.R. buffer 
pH 5.8 with l~~ methanol. DSCG concentration: 
(i) 0, (ii) 0.04, (iii) 0.14, (iv) 0.53, (v) 0.92, 
(vi) 1.31, (vii) 2.14 wg/ml. 
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Fig, 5. Calibration curve of DSCG in B.R. buffer solution with 
10'tb methanol. 
Polarography of DSCG in urine 
As we expected, it was· necessary to separate DSCG from urine 
before the polarographic determination step. This is due mainly 
to the presence of naturally occurring electroactive constituents 
which interfere with the measurements and consequently limit the 
applicability of the technique for the determination of low drug 
levels in urine. Ion-pair extraction of DSCG into an organic solvent 
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was tried first. Benzalkonium chloride (Benzyldimethyloctadecylammonium 
chloride) and tetrabutylammonium chloride were tried first unsuccessfully. 
Several other phosphonium salts were also tried, but tri-n-butylbenzyl-
phosphonium chloride was readily soluble in water and gave low 
polarographic blanks. This compound was found to extract DSCG 
effectively from urine samples spiked with DSCG, and from aqueous 
standards (pH 2-9) into .chloroform. However, extraction at an 
acidic pH was used throughout this study because it has the attendant 
advantage of lessening the risk of emulsion formationS. 
Attempts were made to extract interferents from the urine into 
chloroform at the physiological pH of the urine before DSCG was 
extracted with the phosphonium salt. Good recovery of DSCG was 
obtained but the base line was no better: a considerable improvement 
was observed, however, when pre-extraction of the impurities was 
done with n-butanol. Other extractive clean-up procedures with 
iso-amyl alcohol and hexane were tried unsuccessfully. No loss of 
DSCG was observed due to the pre-extraction of the urine samples 
spiked with DSCG with n-butanol. 
Typical differential pulse polarograms obtained from urine samples 
spiked with DSCG by the above method are shown in Fig. 6a. Polarograms 
obtained after extraction of aqueous standards are shown in Fig. 6b. 
Comparison of the height~ of these peaks with those obtained with 
aqueous standards without extraction indicated that the recoveries 
of DSCG from aqueous standards and from urine samples were 95% 
and 73'fo respectively. The relative standard deviation obtained 
for the ,,:determination of DSCG at the 1 ~g/ml level in urine 
(10 determinations) waa 4%. 
The concentration of the phosphonium salt in the polarographed 
solution affected the height of the d.p.p. peak of DSCG. Jacobsen, 
E., et al9 have shown that surface-active materials have this (j,ffect. 
The effect of different concentrations of phosphonium salt on the 
peak height of 3.9 x 10-6M DSCG standard solution is shown in 
Table 2. 
Table 2. Effect of various concentration of the phosphonium 
salt on the peak height of DSCG standard solution 
-6 (3.9 x 10 M) 
Phosphonium salt Peak height uA 
concentration 
-6 3.9 x 10 M 0.34 
1.96 x 10-2r.! 0.30 
3.90 x 10-2r.! 0.28 
7.80 x 10-211 0.24 
The peak height of a standard solution of DSCG (3.9 x 10-~) in 
B.R. buffer pH 5.8 was 0.26 ~A. From the above information, it can 
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Fig. G. Typical d.p. polarograms obtained for DSCG: after extraction 
with tri-n-butylbenzylphoBphonium chloride from (a) urine and 
(b) aqueous standard for DSCG concentration of (i) 0, (ii) 1.75, 
(Hi) 2.5 (iv) 5 \lg/ml. 
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be seen that, the addition of an equimolar amount of 
tri-n-butylbenzylphosphonium.chloride to DSCG at the 10~ level 
(pH 5.8) increased the height of DSCG d.p. peak by 30'~,much larger 
concentrations of the phosphonium salt, however, depressed the height 
of the peak. So, the amount of the phosphonium salt used in 
the extraction of standards and samples should be controlled fairly 
closely. 
u.v. spectrophotometry, was used to determine the amount of 
tri-n-butylbenzylphosphonium chloride co-extracted with the DSCG 
in the chloroform. First, a U.V. spectrophotometric method was 
developed for phosphonium salt determination in aqueous solutions. 
A rectilinear calibration curve was obtained over the concentration 
range 1 x 10-3 - 2 x 10-~. The results are shown in Table 3. 
Table 3. Results obtained for the spectrophotometric 
determination of phosphonium salt in aqueous 
solutions. 
Phosphonium salt Absorbance at 
concentration. 258nm 
1 x 10-\! 0.082 
2 x 10-3r.! 0.157 
3 x iO-3M 0.236 
4 x 10-\! 0.315 
1 x 10-~ 0.780 
2 x .10-<11 1.500 
The amount of phosphonium salt co-extracted with DSCG was 
obtained by subtracting the amount left in the aqueous layer from 
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the total amount of the phosphonium salt added. In order to determine 
the amount of phosphonium salt left in the aqueous layer, four 
identical aqueous standard sample, solutions were extracted as 
recommended above and the absorbance of the aqueous layers were 
measured. The results are shown in Table 4. 
Table 4. Results obtained for the determination of the 
phosphonium salt left in the aqueous layer. 
Sample No. Absorbance of aqueous layer at 258nm (measured in O. -5 cm cells) 
1 0.655 
2 0.653 
3 0.655 
4 0.655 
The amount of phosphonium salt left in the aqueous layer was found -
by comparison of the absorbance with those of standards - to be 
27.5mg; it follows that 98.2mg of phosphonium salt was co-extracted 
with DSCG. The addition of this amount to an aqueous standard 
solution of DSCG at 10-6M level left the d'-p. peak of DSCG 
unchanged. 
DSCG was found to be effectively extracted as cromoglycic acid 
(pK = pK = 2.0) into ethyl acetate from aqueous standards and 
a1 , a2 
urine samples spiked with DSCG. The interferents in the urine were 
first extracted from urine at the physiological pH of the urine with 
ethyl acetate before extracting the DSCG as the free acid at lower 
pH. DSCG was recovered from the ethyl acetate by evaporating the 
ethyl acetate to dryness then dissolving the residue in 0.5ml of 
methanol and 4.5ml B.R. buffer solution pH 3.4. Alternatively the 
0000 may be back-extracted into 2ml of 2M sodium hydroxide solution. 
In this case, add 3ml B.R. buffer (pH 1.9). The latter procedure 
does not work well with urine samples. 
The recovery of DSoo from urine sample by the ethyl acetate 
method exceeded 95'~ and the relative standard deviation (10 
determinationsJ at the 1 llyml level was 'Jl~. Typical differential 
pulse polarograms obtained by this method are shown in Fig. 7. 
The polarograms obtained when the phosphonium salt extraction 
was used seemed to be better, as indicated by a less steep base 
line. This may be due to the fact that ion-pair extraction is more 
selective and the amount of interferents co-extracted are less than 
in the case of ethyl acetate extraction. Even so, interferents 
in the urine produced a fairly steep base line and restricted the 
determination to 0.5 llyml DSCG in urine, compared with 0.04 llyml 
DSoo in aqueous standards. 
The differential pulse polarographic procedure for the 
determination of DSCG in urine samples covers approximately the 
same concentration range as the calorimetric procedure2 ,5 •. The 
clean-up procedure recommended for use with the polarographic method, 
however, is simpler and quicker than that used with the colorimetric , 
method and avoids the use of ion-exchange resins and concentrated 
formic acid solutions. In addition to the long analysis time of the 
2 . 
colorimetric method (> 2 hours), Moss, G. et al reported that 
the rate of the application of the urine sample to the ion-exchange 
column was critical: faster rate than about 0.5 mljmin gave lower 
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recoveries, whereas, slower rates gave higher blank readings. Further, 
Curry and Mills5, to obtain sufficient precision when formate-treated 
resins were used, found it necessary to use a radioactive internal 
standard to determine the DSCG recovery. In contrast, the precision 
of the polarographic method is good. The concentration of electro-
active constituents in urine samples varies with the time of sampling 
and by the physiological state of the patient at the time of 
sampling. In the present work, a higher concentration of the 
electroactive interferences - indicated by steeper base lines -
was observed in early morning samples, so that samples taken later 
in the day are to be preferred. 
10 11 Previous authors ' have commented on the fact that half-
wave and peak potential of organic compounds in, or after extraction 
from, biological fluids, can differ from the potentials of the same 
compounds measured directly in aqueous solutions. This was true in 
the present work, the peak potential of DSCG extracted from urine 
being some 60mv more positive than that obtained directly in aqueous 
buffer at the same pH. 
The polarographic method should be readily adaptable to the 
determination of DSCG in formulations, and should be parUcularly 
valuable in stability testing as the drug can be determined without 
derivatization. 
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Fig. 7. Typical d.p. polarograms obtained after extraction 
of cromoglycic acid into ethyl acetate from urine for 
DSCG concentrations (i) 0, (ii) 0.5, (iii) 1.0, (iv) 2.5, 
(v) 5 llg/m1. 
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SPECTROPHOTOMETRIC AND DIFFERENTIAL PULSE 
POLAROGRAPHIC DETERMINATION OF SULPHAGUANIDINE 
BY REACTION WITH HYPOCHLORITE AND PHENOL 
Introduction 
The sulphonamides constitut,e a very important class of 
antimicrobial agents, and still sustain an important place in 
the chemotherapy of infectious diseases. Sulphapyridine, the 
preparation of which was reported in 1938, was one of the earliest 
sulphonamides to be used with gre~t success in clinical practice 
for treatment of pneumonia. Over 3300 sulphonamides, however, 
have since been prepared, but only a few have been accepted for 
medicinal use1• The antimicrobial spectrum of all sulphonamides 
is essentially the same, but they may vary widely in their 
absorption, excretion and distribution characteristics. 
Sulphaguanidine, which is absorbed to a varying degree from 
the gastrointestinal tract after oral administration is used for 
the treatment of local intestinal infections, particularly bacillary 
dysentery. The use of suiphaguanidine is now largely suppressed 
by the use of the less toxic sulphonamides, phthalylsulphathiazole 
and succinylsulphathiazole2• 
Generally, most of the therapeutically useful, antimicrobial 
sulphonamides are characterised by the following structure: 
Structure I 
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The different sulphonamides are formed by varying the substituents Rand 
R. 
A wide range of analytical methods is available for the determination 
of sulphonamides. Traditionally, these drugs ,~ere analysed by paper 
chromatography and colorimetr~. Recently, high performance liquid 
chromatography was extensively applied to the analysis of sulphonamides 
in pharmaceutical dosage forms, body fluids and tissues4• 
In this work, the formation of a coloured product possibly an 
indophenol compound was made the basis of colorimetric and 
differential pulse polarographic (d.p.p.) methods for the determination 
of sulphaguanidine. 
Indophenols have the general structure 115 
, 
R=R=H 
Structure 11 
These compounds are usually intensely coloured,and their physical and 
chemical properties such as colour, acid-base and redox behaviour are 
affected by the introduction of various functional groups into the 
indophenol molecule. 
Indophenol derivatives have been used frequently in analytical 
chemistry. They have been extensively employed for many years as 
redox indicators6, as a titrant for the determination of ascorbic 
aCid7,8 and as acid-base indicator9• Some indophenols are used as 
spray reagents in paper chromatography10, and as standards in 
chromatographic separations11 • Esters of indophenols have been used 
as chromogenic substrates for the estimation of acetylcholinestrase 
activity12. 2,6-Dichlorophenolindophenol was used for the 
detection of bacteriological contamination in foodstuffs13• 
The formation of an indophenol dye when ammonia solution was 
heated with an alkaline solution of phenol and hypochlorite was 
used by·Thomas in 1912 to determine very low levels of ammonia14• 
Orr in 192415 used the reaction for the direct determination of 
ammonia in urine, and Hurray (1925) 16 for determination of blood 
urea. The reaction has been used by several investigators after 
slight modification~7-23. Fairly recently, it was reported that 
the addition of sodium nitroprusside as a catalyst does not only 
accelerate the speed of the reaction but also increased to a 
maximum the conversion of ammonia to indophenol dye24- 29• 
The condensation of quinonechlorimide and phenol to produce an 
indophenol dye was first described by Hirsh (1880)30. This 
raaction has been made the basis for an extremely sensitive method 
for the· quantitative determination of phenolic compounds31 ,32. 
Vignoli et al (1965)33 developed a colorimetric method for the 
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determination of sulphonamides. In that method, a coloured product was 
formed (suggested to be quinoneimine)when sulphonamides were made to 
react with chloramine T in presence of phenol. Bratton et al(1939)34 
described a colorimetric method for the determination of sulphanil-
amide • The method was applicable to all sulphonamides containing a 
free primary amine group which in the reaction, is diazotised and 
coupled with N-(1-naphthyl)ethylenediamine dihydrochloride. Welch 
et al(1965)35 described a colorimetric method for the determination 
of N-acetyl-p-aminophenol in urine. The method involves the hydrolysis 
of N-acetyl-p-aminophenol with acid to p-aminophenol which is then 
coupled directly with phenol in the presence of hypobromite to form an 
indophenol dye. 
Automatic36 and manua137 colorimetric methods for the determination 
of paracetamol and phenacetin based on the indophenol reaction have 
been described. Paracetamol and phenacetin were made to react with 
acidified hypochlorite solution to form a quinonechlorimide which in 
turn reacts with phenol to form an indophenol dye. Davis et al 
(1974)38 developed an alternative manual procedure for the determination 
of phenacetin and paracetamol. In this latter procedure, paracetamol 
and phenacetin were first hydrolysed to p-aminophenol and 
p-phenetidine respectively, before reaction. with hypochlorite to 
form p-quinonechlorimide, which then undergoes a reaction with phenol 
to form an indophenol dye. Ellcock and Fogg in 197539 described a 
simple method for the determination of paracetamol. The method 
involves the spontaneous oxidation of alkaline mixture of p-aminophenol 
(obtained as a result of paracetamol hydrolysis in hydrochloric acid 
solution) and phenol with molecular oxygen to form an indophenol dye. 
Ellcock and Fogg (1974)40 found it necessary to introduce sodium 
nitroprusside as a catalyst when they applied a method similar to 
that of Davis et a138 for the colorimetric determination of 
sulphanilamide. The catar-yst was found to be particularly effective 
in the reaction of sulphanilamide with alkaline phenol and 
hypochlorite. Finally, Fogg and Ahmed (1978)41 applied differential 
pulse polarography (d.p.p.) for the determination of ammonia, 
p-aminophenol and sulphanilamide at the lO-7M level after indophenol 
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derivatization. They found that d.p.p. can be conveniently applied 
as an alternative near the limit of the colorimetric procedure. 
~ Ellcock and Fogg noticed that sulphaguanidine gave a green-yellow 
colour with A at 450nm when it reacted with alkaline phenol and 
m~ 
hypochlorite solutions in the presence of sodium nitroprusside as a 
catalyst. This was in contrast with the blue indophenol colour given 
by sulphanilamide under the same experimental conditions. The authors 
suggested that, the reaction could be made the basis of a colorimetric 
method for the determination of sulphaguanidine. 
In the present work, the reaction between sulplwguanidine and 
alkaline phenol and hypochlorite was studied in more detail, 
particularly, the various factors which affect the coloured product 
formed. The initial reaction conditions used were those of 
sulphanilamide assay~. 
On the basis of these studies, a calorimetric method for the 
determination of sulphaguanidine was developed. Further, the coloured 
product formed gives a well-defined polarographic wave~ This wave 
was used as the basis for a selective, precise and s~nsitive procedure 
for the determination of sulphaguanidine. The polarographic procedure 
was finally applied to the determination of the sulphaguanidine contents 
of a commercial sample of Guanimycin Suspension Forte. 
Experimental 
Equipment. Colorimetric measurements were made with 'a Pye Unicarn 
SP 600 spectrophotometer using 1 cm cells. Polarographic measurements 
were made with a PAR 174 polarographic analyser as described for the 
previous work. 
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Reagents 
All reagents were of analytical reagent grade except where otherwise 
indicated. 
Sodium hypochlorite solution. Dilute 20ml of commercial sodium 
hypochlorite solution (10-14% available chlorine) to 500ml with 
distilled water. 
Sodium hydroxide solution (lOM). Dissolve 40gram of sodium hydroxide 
in distilled water and dilute the solution'to 10Oml. 
Phenol solution, 3% w/v. Dissolve 3 gram of phenol in 100ml 
distilled water. (Care should be taken in handling concentrated 
phenol solutions to avoid contact with skin). 
Sodium nitroprusside solution. Dissolve 0.1 gram of sodium 
nitroprusside in 250ml distilled water. 
Standard sulphaguanidine solu~o~ 2.8 x 10-4M• Dry sulphaguanidine 
to constant weight at 1050 C, dissolve 0.600 gram in a little dilute 
hydrochloric acid and dilute the solution to 100 ml with distilled 
water in a volumetric flask. Two further dilution (1Oml~lOOml) 
gave a 2.8 x 10-4M sulphaguanidine standard solution. 
Guanimycin Suspension Forte. Supplied by Allen and Hanburys Ltd., 
Ware, Herts. 
Results and Discussion 
The following set of experiments were carried out in order 
to optimise the experimental conditions which produce the maximum 
colour intensity. 
Optimisation of sodium hydroxide concentration 
Into six 50ml volumetric flasks, from 1-6 ml of sodium hydroxide 
solution (lOM) were pipetted. The required volume of distilled water 
was added to each flask to bring the final volume to 6ml. To each 
of these flasks, 5ml of sodium nitroprusside, 5ml of sulphaguanidine 
solution (2.8 x 10-4M). 5ml of 3% w/v phenol solution, and 5ml of 
sodium hypochlorite solution were added. The flasks were heated in a 
water bath at 45°C for 15 minutes. The solutions were cooled and 
diluted to 50ml with distilled water. The absorbance was measured at 
450nrn against water as a reference in 1 cm cells. The results are 
shown in Table 1. 
Table 1. Effect of sodium hydroxide concentration on the 
apparent molar absorptivity of the coloured 
product formed. 
Sodium hydroxide 0.38 0.76 1.14 1.52 1.9 concentration(H) 
Apparent molar 
absorptivity/ 1.64 1.21 0.68 0.67 0.54 
4 -1-1 10 1 mol. cn 
The optimum concentration of sodium hydroxide is 0.38M. 
Optimisation of sodium hypochlorite concentration 
2.28 
0·57 
The experiment was repeated as before, except that the sodium 
hydroxide concentration was fixed to 0.3811 and different volumes of 
sodium hypochlorite stock solution were used. The results are shown 
in Table 2. 
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Table 2. Effect of sodium hypochlorite concentration on the 
apparent molar absorptivity of the coloured product 
formed • 
Volume of sodium 
hypochlorite 1 2 5 10 15 
added (ml) 
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20 
Apparent molar 4 
absorptivity/1O 0.82 l.41 1.69 1.85 1.64 1.46 
-1 1 mol cm -1 
The optimum volume of sodium hypochlorite is 10ml. 
Optimisation of sodium nitroprusside concentration 
Into eight 50ml volumetric flasks, from 0-7 ml of sodium 
nitroprusside solution (0.04% w/v) were added. The final volume 
was brought to 7ml with the required volume of distilled water. To 
each flask, 5ml of phenol solution (3% w/v), 1 ml .<of sodium hydroxide 
(1OM) 5ml of sulphaguanidine standard solution and lOml of sodium 
hypochlorite solution were added, and the experiment carried out as 
before. The results are shown in Table 3. 
Table 3. Effect of sodium nitroprusside concentration on the apparent 
molar absorptivity of the coloured product formed. 
Concentration 
of sodium 0.0 0.0014 0.0028 0.0042 0.0057 0.0071 0.0086 nitroprusside 
solution/per 
cent w/v 
Apparent 
molar abso~-
ptivity/10 1.75 1.67 1.60 1.67 1.71 1.71 1.73 
-1 -1 1 mol cm 
From the above information, it is apparent that sodium nitroprusside 
has no significant catalytic effect on the formation of the coloured 
product, so, this reagent was omitted subsequently. 
0.01 
1·73 
Optimisation of phenol concentration 
In this experiment, the same concentrations of sulphaguanidine, 
sodium hypochlorite and sodium hydroxide were used as above in the 
presence of varying phenol concentrations, but in the absence of 
. 
sodium nitroprusside~ The results are shown in Table 4. 
Table 4. Effect of phenol concentration on the apparent molar 
absorptivity of the coloured product formed. 
Phenol concen-
tration/per 0.23 0.46 0.,58 0.69 0.92 1.15 
cent w/v 
Apparent molar 4 
abs'Jrptivi ty/10 0.89 1.14 1.42 1.39 1.23 1.12 
-1 -1 1 mol cm 
From the above results, the optimum phenol concentration is seen 
to be 0.,58% w/v. 
Effect of heating time 
The effect of heating time on the colour intensity was studied 
at 45°C at the optimum reagents concentration, namely, sodium 
hydroxide concentration of 0.38M, sodium hypochlorite solution (lOml 
of about 0.4% available chlorine), phenol solution concentration of 
0.58% vI/v, and sulphaguanidine standard solution 2.8 x 10-4M• 
Results are shown in Table 5. 
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Table 5. Effect of heating time on thg apparent molar absorptivity 
of the colour obtained at 45 c. 
Heating time/min 5 10 15 20 25 30 35 
Apparent molar 4 
absorpti vi ty /10 1.64 1.64 1.48 1.0 ,0·75 0.60 .0.43 
-1 -1 1 mol cm 
From the above results, the optimum heating time is seen to lie 
between 5 and 15'minutes. 
Stability of the colour obtained with time. 
The previous experiment was repeated with 10 minutes heating time, 
and the absorbance of the coloured product was measured with time 
at room temperature. The results are shown in Table 6. 
Table 6 Effect of standing time at room temperature on the colour 
intensity obtained after heating for 10 minutes at 450 C 
Standing time/min 4 9 13 18 23 29 35 
Apparent molar 4 
absorpti vity/10 1.73 1.66 1.61 1.55 1.42 1.41 1.35 
1 mol-1cm -1 
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Recommended procedure for the colorimetric determation of sulphaguanidine 
To a 50ml volum~tric flask add, in the following order, lml of 
10M sodium hydroxide solution, 5ml of aqueous 3% (w/v) phenol solution, 
5ml of sulphagUanidine standard solution or sample (contains less 
than 0.4mg of sulphaguanidine), and 10 ml of sodium hypochlorite 
solution. Heat the flasks in a water bath at 45°C for 10 min, cool, 
dilute to 50ml with distilled water, and immediately measure the 
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absorbance at 450nm in l-cm cells. Subtract the absorbance of a blank 
determination containing no sulphaguanidine. 
A rectilinear calibration curve obtained with the above 
procedure in the concentration range 0.5 - 4.5 x 10-~ is shown in 
Fig. 1. The slope of the calibration curve corresponded to a molar 
absorptivity of 1.65 x 104 1 mol-1cm-1 for the coloured product, 
assuming a 1:1 molar conversion from the sulphaguanidine. The 
coefficient of variation (eight determinations) at the 2.8 x 10-5M 
level in the measured solution was 1%. 
Polarographic procedure 
The procedure adopted was the sa~e as the colorimetric procedure 
except that 5ml of ethanol was added after the heating step and before 
dilution to 50ml with distilled water; in the absence of ethanol 
the polarographic wave is distorted by an adsorption wave. Deoxygenation 
is affected by passing oxygen free nitrogen gas through the solution 
for 7 minutes. The d.p.p. curve is then immediately recorded between 
-0.4 and -a.8v. 
Typical differential pulse polarograms are shown in Fig. 2. 
A rectilinear calibration curve obtained in the concentration 
range 0.5 - 4 ~gJml as shown in Fig. 3. The coefficient of variation 
at the 2 ~g/ml level was 2.4% (10 determinations). 
Application of the polarographic method to determine the sulphaguanidine 
content of a commercial sample of Guanimycin Suspension Forte. 
The sample (lg) was weighed into a 50ml beaker and mixed well 
with 20ml of distilled water and 2ml of concentrated hydrochloric 
acid. The mixtUre was transferred to a lOOml volumetric flask, 
lLJ 
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~O. 
co 
« 
0.2 
o .0L-------'-2----4"'-------' 
CONCENTRATION x10-5M 
Fig. 1. Calibration graph obtained for sulphaguanidine 
by the spectrophotometric method. 
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Fig. 3. Calibration graph obtained for sulphaguanidine by d.p.p. 
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diluted to volume with distilled water, and filtered through a sintered 
glass crucible; lOml of the filtrate was diluted to lOOml in a volumetric 
flask. Further dilutions (lOml--10Oml followed by 2Oml--100m1) 
were made, and aliquots (5ml) of the final solution were used for the 
determination. The sulphaguanidine equivalent in the final solution 
was found by comparison of the d.p.p. peak height with those of 
standard to be 2.15 ~g/ml. This corresponds to 2.1g of sulphaguanidine 
in l5ml of Guanimycin Suspension Forte compared with the 1.98g nominal 
content. 
Behaviour of other sulphonamides. 
The behaviour of several other sulphonamides under the reaction 
conditions of the recommended procedure was studied. None of these 
was observed to react at the same low levels as sulphaguanidine. 
For sulphanilamide at the 10-3M level the blue indophenol colour 
and the polarographic peak were observed but the extent of the reaction 
41 was much less than would be the case with nitroprusside present • 
Further, a shift in the position of the polarographic peak of 0.17V 
to more negative potential was observed under the present experimental 
conditions. Sulphasolucin gave the same blue indophenol colour and a 
polarographic red,uction ~/ave at -0.5V, but the extent of the reaction 
was also less than sulphanilamide. Sulphadiazine at the 10-~ level 
was observed to give the yellow colour and a polarographic wave: the 
absorbance and peak current obtained were consistent with about 10',6 
of the sulphadiazine·reacting. Two other pyrimidine sulphonamides, 
sulphamerazine and sulphadimidine, and also sulphapyridine gave a 
slight reaction at the 10-~ level indicating about 1% reaction. 
No colour reactions or polarographic waves were obtained for 
guanidinium chloride and benzene sulphonamide under these reaction 
conditions. The result for the above sulphonamides and other 
sulphonamides are summarized'in Table 7. 
Good precision was obtained using the c,olorimetric and the 
polarographic methods, but, the alkalinity of the solution is critical. 
The addition of 2ml of 10M sodium hydroxide gives an apparent molar 
absorptivity 4 -1-1 of only 1.21 x,lO 1 mol cm compared with apparent E 
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of 1.64 x 10 1 obtained when lml of lOM sodium hydroxide 
was added. So, the concentration of sodium hydroxide solution 
should be controlled fairly closely for standard and sample. The 
concentration of phenol and hypochlorite are less critical, but 
nevertheless, the volumes added should also be controlled quite 
closely. Calibration graphs should be prepared for each new batch of 
hypochlorite reagent solution. 
The colour intensity decreases rapidly for heating times greater 
than 10 minutes (e.g. apparent 8 = 1.48 and 0.75 x 104 1 mol-1cm-1 
after 15 and 25 minutes respectively). Loss of colour intensity after 
cooling to room temperature is much slower (e.g. apparent 8 = 
1.35 x 1041 mol-1cm-1 after heating for 10 minutes followed by a 
standing period of 35 minutes). 
The presence or absence of sodium nitroprusside was found to 
have no significant affect on the apparent molar absorptivity of the 
coloured product formed. This was advantageous as nitroprusside gives 
an appreciable blank owing to the formation of nitropentacyanoferrate 
42 in alkaline solution • 
2-Fe(CN)SNO + 20H 
Table 7. Results obtained for number 
of sulphonamides under the 
reactiondconditions of the 
recommen ed procedure 
Substituents 
Name R R' 
,NH 
Sulphaguanidin -H -C 
'NH 2 
Sulphanilamide 
-H -H 
Sulphadiazine -H -<~=> 
Sulphapyridine 
-H 
-0 
Sulphamerazine 
-H 
-<=3H3 
Sulphadimidine -H -<N~H3 
N CH3 
Sulphasomidine -H -rlH3 
N-{H 
Sulphathiazole -H ij , 
Succinylsulpha 
-CO,(CH2)2COZH jj thiazole N, 
HOb !j Phthalylsulpha co thiazole 
Lf Sulphaphenazol -H 
Sulphamethizol 
-H tf' 
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Colour D.p. p. 
Reaction peak Remarks 
positio 
Green- All 
yellow -O.63V concentra-
colour tions. 
Blue -O.50V 11 
colour 
Yellow 
-o.58v At high 
colour concentra-
tion only 
11 
-o.58v 11 
11 
-o.6ov 11 
11 
-o.6ov 11 
No colour No peak -
11 11 
-
11 
" 
-
11 
-O.56V At high concentrat-
ion only 
11 
-O.56v 11 
11 
-O.56v It 
41 Further, Fogg and Ahmed found it necessary to remove excess 
nitroprusside ion from the reaction mixture by the addition of sodium 
sulphite solution as the presence of excess sodium nitroprusside 
gives a d.p. polarographic peak at -Q.27V which interferes with the 
measurements. 
The polarographic behaviour of six indophenols has been studied 
by Patrick R.A. et al 43. They suggested that all indophenols were 
reduced reversibly at the dropping mercury electrode, showing a well-
defined polarographic wave. The wave was found to be diffusion 
controlled and corresponds to the addition of two electrons and two 
protons according to the following scheme: 
The sensitivity of the polarographic method for the determination of 
.sulphaguanidine is about 10 times greater than the. colorimetric method, 
and could be applied advantageously to determine sulphaguanidine in 
turbid and coloured solutions. Satisfactory results were obtained when 
the polarographic method was applied to determine sulphaguanidine in 
Guanimycin Suspension Forte. 
The colorimetric and the polarographic methods are more 
selective than the colorimetric method developed by Bratton et 6134 
that is applicable to all sulphanomides that have a free primary 
aromatic amino group. Both methods described in this work could be 
applied with advantage in application which require identification 
as well as determination. The nature of the green-yellow colour is 
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not known: the colour remains unchanged on acidification. When 
sulphaguanidine'is oxidised with hypochlorite under:acid conditions, 
followed by reaction with phenol in alkali, _it_gives a 
blue colour (apparent £ = 1.07 x 1041 mol-1cm-1 at 625nm)38• 
The blue product obtained with sulpheguanidine possibly has structure 
III although this has not been confirmed. 
Structure III 
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DIFFERENTIAL PULSE POLAROGRAPHIC STUDY OF CEPHALOSPORINS 
AND THEIR DEGRADATION PRODUCTS 
Intraductian 
Penicillins and cephalasparins, which are cammanly referred 
to. as the S-lactam antibiatics, are amang the aldest and mast 
impertant classes ef naturally accurring antibietics used in 
antimicrabial chemetherapy. The impertance ef these antibietics 
is due to. their inhibitian af the terminal step in bacterial cell 
wall synthesis1 Cephalosporin C2 is the parent sUbstance frem 
which the first cephalesperins to. find clinical use were derived. 
Cephalesperin C was discevered at Oxfard during a chemical study 
ef the structure ef penicillin N3 • This substance which was faund 
to. have antibacterial activity, resembles penicillin N in seme ef 
its chemical and bielegical praperties, but differed frem it strikingly 
in ethers. The antibacterial activity ef cephalesperin C in vitro. 
was lew, but the apparent relatienship af the sUbstance to. the 
penicillin family, ceupled with its resistance to. penicillinase frem 
staphylececcus aureus4 , gave it at ence a petential clinical interest. 
All penicillins which can be made by fermentatien have a 
6-acylamide' greup ef the general structure R-CH2-CONH, while, in the 
case ef cephalesperin C, there are two. side chains attached to. the 
cephalesperin nucleus. The iselatien of the penicillin nucleus, 
6-aminopenicillanic acid (6-APA), in 19595 , and the cephalesparin 
nucleus, 7-aminacephalasperanic acid (7-ACA), in 19616 has permitted 
the preparatien ef numereus semisynthetic penicillins and 
cephalesperins (by varying the side chain greups) which ceuld net be 
prepared by biesynthesis. 
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These chemical modifications have been designed especially 
to produce penicillins and cephalosporins with more desirable 
properties, such as improved acid stability, broadened microbiological 
spectrum, decreased allergenicity and improved metabolic or 
pharmac~logical efficiency such as slow excretion, better tissue 
diffusion and better oral absorption. 
In contrast to the large number of side chains which give 
penicillins and cephalosporins with high activitY,very little 
change can be tolerated in the nucleus before antimicrobial activity 
is markedly reduced or lost altogether. 
Within the last few years several excellent reviews covering 
7-12 the chemistry , structure activity relationships13-15, 
16-18 pharmacology and clinical aspects19 :of semisynthetie- S -lactam 
antibiotics have been published. 
Structure of B -lactam antibiotics 
All S-lactam antibiotics are derivatives of a bicyclic ring 
system. All, with the exception of 6-amino-penicillanic acid 
(6-APA) and 7-aminocephalosporanic acid (7-ACA>", have an acyl group 
attached as a side chain to the amino group of the B -lactam ring. 
The penicillin molecule consists of a nucleus and a condensed 
side-chain group. The nucleus contains a four-mernbered fl -lactam 
ring fused with a five-membered thiazolidine ring. The basic 
structure of penicillin is shown below. 
R-C-,-~' ,.S, /CH3 
11 I .O-c., C, 
o I H/ I I 'H I CH3 
I C-til-C 
: if 1 "'COOH 
l f H 
: Thiazolidine ri~1 g 
I f3-lactam ring 
• I 
Side-chain groupA 6 -Aminopenicillanic ac d 
(Penici lli n nUcleUS): 
BASIC STRUCTURE OF PENICILLlNS 
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The cephalosporin ring system differs insofar ls the four-
membered ~ -lactam ring is fused with an unsaturate~ six-membered 
dihydrothiazine ring. The basic structure of cepha~osporins is shown 
below. I 
H H Rf~-'- N,C_(,:~S,C/ 
O· I r'H~'H C-N if 'c: 'CH -R I 2 2 
COOH 
t 
6 3 -DihYdr,othirZine 
ring 
)3-lactam ring 
S ide-chai n g roupA 7 -Aminocephalosporanic acid 
(Cephalosporin nuclJus) 
BASIC STRUCTURE OF CEPHALbsPORINS 
~he different penicillins are formed by altering thJ 6-amino side-
chain and the different cephalosporins by altering 1rre 7-amino side-
chain and, in some cases, the 3-methyl substituent •. The structure 
of some cephalosporins of clinical importance have been listed in 
Table 1. 
Table 1. 
NAME R 
SUBSTITUENT 
R' 
CEPHALOTHIN 
QCH2CO-
-OCOCH3 
+ 
CEPHALOSPORIN H3N):H(CHi3CO- -oCOCH3 
C -OOC 
+ 
DESACETYL- HN 
CEPHALOSPORIN 3 ):H(C~)3CO- -OH 
C IoOC 
£1 
CEPHOXAZOLE <- "\. r.o. -OCOtH3 
.#' ~'O' -CH.J 
. H- -OCOC~ 7-AMINOCEPH-
ALOSPORANIC 
ACID 
7-AMINODESACET- H- -H 
8HN2F~8~SP-
NAME 
CEPHALEXIN 
CEPHALORIDINE 
CEPHALONIUM 
CEFUROXIME 
CEPHRADINE 
RHNI1,SI·, 
o N~~ 
COOH 
SUBsmUENT 
R R' 
< )yHCO- -H N~ 
U~CO- -N8 
OC~CO- -N~ ).cON~ . 
. 
Ck-co- -OOCNH2 
N-OC~ 
< )-yHCO-N~ -H I -.J -" 
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Analytical methods of determining cephalosporins and penicillins 
Many techniques have been described for the analysis of 
cephalosporins .. These techniques in many instances were applied 
previously to the determination of penicillins. This is due 
mainly to the structural similarity of cephalosporins and penicillins. 
The methods of determination can be classified as follows:-
1. Microbiological determinations: 
a. Plate assays. 
b. Photometric assays. 
2. Chemical determinations: 
a. Iodometric method. 
b. Hydroxylamine method. _ 
c. Ninhydrin colorimetric method. 
d. Nic'otinamire method. 
3. Chromatographic methods: 
a. Paper and thin layer chromatography. 
b. Iligh.performance liquid chromatography (HPLC). 
c. Column chromatography. 
4. Physicochemical method. 
This category includes U.~, I.R., N.M.R., optical rotatory, 
x-ray diffraction, spectrofluorimetric and polarographic methods. 
73 
11ethods in the first two sections provide quantitative results, 
while those in the other sections serve in addition to identify 
the J3 -lactam antibiotic (or its metaboli tes or impurities)." 
Recently two reviews covering most of the analytical techniques 
20 21 
used to assay penicillins and cephalosporins have appeared ' 
Polarography of cephalosporins and penicillins 
Microbiological assay of antibiotics is the accepted technique 
for measuring antibacterial activity. This technique is time 
consuming and lacks the capability to function as a rapid screening 
technique. Often, more information than just antibiotic activity 
is required. In the development of a new antibiotic species, the 
analytical chemist is required to develop analytical methods for 
formulation stability, quality-control and drug metabolism studies. 
For formulation stability stUdies a precise and specific method is 
needed to discriminate between the parent antibiotic and its 
degradation products, while in quality-control it is necessary to 
ensure that the antibiotic is not contaminated with unacceptable 
amounts of starting materials or reaction by-products. In 
metabolic studies, specific and sensitive methods are required to 
assay antibiotics in the presence of their metabolites. Polarography 
and especially differential pulse polarography appears to be a 
satisfactory technique capable of solving most of the above problems 
providing that the compounds sought are polarographically active. 
The first report of the d.c. polarographic determinations of 
cephalosporins seems to be that of Jones et al in 196822 • The 
authors showed that cephalosporin C, cephalothin and cephaloridine 
each exhibits a reduction wa"re at the dropping mercury electrode (d.m. e). 
They suggested that only the cephaloridine d.c. wave could be used 
for quantitative determinations, while use of the ill-defined 
waves of cephalothin and cephalosporin C should be restricted to 
qualitative purposes. 
Benner23 determined several penicillins in addition to 
cephalothin, cephaloridine and cephalexin in serum by cathode-ray 
polarography, the latter compound being determined after hydrolysis 
in sodium hydroxide solution at 500C for 30 min. He claimed that 
the peak obtained for cephalexin Wa~ very stable and allowed the 
determination of cephalexin with an accuracy of ~ 1 ~g/ml in the 
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range 1-10 ~g/ml. Hal124 has used d.c. polarography and coulometry 
in a study of the degradation of 3-(5-methyl-1,3,4-thiadiazol-2-
ylthiomethyl)-7-(2-(3-sydnone)acetamido)-3-cephem-4-carboxylic acid, 
sodium salt 1. 
He suggested that acid hydrolysis results in the loss of the 
, 
R-group at the 3-position and the formation of an (1- S -unsaturated 
lactone, while base and enzymatic hydrolysis opens the S -lactam 
/ 
ring and simultaneously eliminates the R-group at the 3-position. 
Ochiai et al 25 have utilized preparative electrolysis and 
polarography in order to study the mechanism of the cathodic 
reduction of cephalosporanic acid derivatives containing various 
substituents at the 3-position. They concluded that the 
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electrochemical reduction of these derivatives gave the corresponding 3-
me'thyIei1e~eepham derivative: IV according to Scher.Je 1. 
I 
Rl-NHri)S 
J-~. CH2 o 
COOR3 
IV 
• 
Scheme 1 
Rl-NHrlSi 
i- ~~CH2-R2 
II 
III 
COOR3 
/ ..... CH2 
COOR3 
They also suggested that the variation of the R1- group does not 
affect the reaction, and the presence of a substituted methyl group 
at the 3-position is the essential requirement for the electrochemical 
reduction of these compounds. Hall et a126 have applied a.c. and 
d.c. polarography, cyclic voltammetry and couloxetry to study the 
electrocher.Jical behaviour of cephalothin in both aqueous and 
non-aqueous soiutions. Recently, Rickard et a127 have used d.c. 
polarography in analytical control and stability testing of ~he 
cephalos?orins, cefamandole and cefamandole nafate, while controlled 
potential coulometry was applied as an absolute measure for purity 
evaluation of these compounds. 
A d.c. polarographic procedure for the determination of cephalexin 
at thelO-3M level after hydrolysis in 5M hydrochloric acid at 800 e 
has been described by Squella et al in 1978~8 
Siegerman29 .reported a differential pulse polarographic method 
for the determination of cephaloglycin in ~! H2S04 at the lppm level. 
Although penicillins are not polarographically active, they 
can easily be converted to species that are amenable to polarographic 
analysis either by derivatization procedures, such as nitrosation30 .. 
or after hydrolysing the penicillins to their polarographically 
active degradation products29 ,31. Krejci32 used polarography in 
a study of the kinetics of penicillin degradation in acidic aqueous 
solution. The use of oscillographic polarography to follow enzymatic 
inactivation· of penicillins r.as also been reported33-34• Recently, 
Jemal et al35,36 studied the polarographic behaviour of 
benzylpenicillenic acid, and used differential pulse polarography to 
follow the degradation of this compound in neutral media. 
The application of d.c. polarography and its more sensitive 
Duccessor, differential pulse polaorgraphy to the determination of 
penicillins and other antibiotics has been reviewed recently29,37-39. 
Degradation of penicillins and cephalosporins 
Penicillins and cephalosporins have been known to undergo facile 
cleavage of their S-lactam bonds in aqueous solution. This has 
evoked a considerable interest in the chemical degradation of these 
antibiotics, as the chemical reactivity of S -lactam moiety is linked 
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with antimicrobial,reactivity40. Further, the instability of these 
antibiotics may lead to the formation of 
involved in penicillin and cephalosporin 
some degradation products 
41-42 
allergy • It is kno\'Ill 
that allergy is mediated by antigen-antib<j'dy reaction, and drug 
molecules of low molecular weight such as penicillins or 
cephalosporins are nonimmugenic themselves. The capacity of these 
compounds to inducc an immune response depends largely on the ability 
of these compounds or their degradation product or mctabolites 
formed in vivo to react covalently with proteins or other tissue 
42 
macromolecules • Once the antibody is formed as a response to 
exposure of the individual to the immugenic substance, it can react 
with the antigen and initiate the allergic reaction. It is apparent 
from the above discussion that a knowledge of the chemical and 
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bioche~ical behaviour of these antibiotics is an essential requirement 
for successful study of their allergenicity. 
Penicillin degradation 
The lability of the penicillin structure has been known from 
the time of the earlier investigations. This lability was attributed 
to the high reactivity of the 8- lactam moiety of the penicillin due 
to the nonplanarity of the S-lactam-thiazolidine structure which may 
cause a great deal of suppression of the usual a~ide resonancc as 
compared with that caused by the dipolar stabilized forms in the 
normal S-lactam structure. This reactivity is reflected by the high 
sensitivity of the penicillins to nucleophilic, electrophilic, and 
43 
oxidizing reagents and even to water • 
In alkaline solution, the initial hydrolysis product of 
penicillin is the biologically inactive penicilloic acid43 • 
This compound is stable in alkaline and neutral solution in the 
form of salts or esters, but on acidification it readily loses 
one molecule of carbon dioxide, forming the corresponding 
penilloic acid43 • Penicilloic acid has been shown to be formed by 
enzymic hydrolysis 
presence of cupric 
of penicillins with S-lactamase44 and in the 
. 45 10ns • 
In concentrated acid solution, penicillins are hydrolysed 
to penillic acid, while in dilute acid or neutral solution, 
penicillenic acid is produced. Penicillenic acid is unstable 
and under a variety of reaction conditions the compound has been 
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shown to rapidly hydrolyse to penillic acid and 4-hydroxymethyleneoxazol-
5(4H)~one46, penicilloic acid47 and penamaladic aCid48 • The end 
hydrolytic degradation products of penicillins are penicilloaldehyde, 
carbon dioxide and penicillamine. The more common penicillin 
degradation pathways are shown in Scheme 2. 
Ampicillin degradation 
Ampicillin (~-aminobenzylpenicillin) is a semisynthetic 
penicillin which contains an ~ -amino group at the 6-side chain and 
which has been shown to be the most acid stable penicillin so far 
. ~ introduced • Ampicillin was found to be effective against gram-
positive and gram-negative organisms50 ,51 and has become one of the 
most widely used antibiotics particularly for the treatment of 
urinary tract infections. 
. I 
CH) SH NH2 . COOH CH SH NH2 . 
'Cl-Cl H-COOH + RCONHCH2CHO _ I + 3,1 I ----.. RCONHCHCHO CH /C-CH-COOH CH~ ) 
Penicillamine Penicilloaldehyde Penaldic acid ~ Penicillamine 
/ RCONHCH !:JCH) RCONH HJS CH) 2 CH) ~.y, 11 CH) 
H:lH) ~ H COOH o~o~N COOH 
RCONHCH"9 CH) Penilloic acid 
... I Penamaldic acid HN COOH 
Penillic acid 
11 
RCONH[1]S ·CH) RCONHI1]S C~ CH) OH-, Cv" C~ 
. COOH orJ3-Lactarnase HN COOH 
o 0 OH 
Penicillin PenicillOic acid 
)COO]~ CH3 ~ CH) • Strong acid R~ COOH 
. H+ JH' 
N CH H.:JCH, 
RJl:JJ . CO~H 
?enicillenic acid "'-l 
'" Scheme 2 
Surprisingly, until recently, very limited work has been done 
on the mechanism of ampicillin degradation. The first study of 
the kinetics and mechanism of ampicillin degradation seems to be 
that of Hou and Poole in 196952 ., who used the iodometric assay 
to monitor the intact penicillin. Depending on classical knowledge 
of penicillin G hydrolysis and DV spectrophotometric measurements 
they postulated a degradation pathway for ampicillin similar to that 
of penicillin G. The authors stated that the amino group side-chain 
of ampicillin plays a significant role in the rate of degradation 
but not on the mechanism of degradation. 
Jusko (1971)53 has shown that a fluorescent degradation product 
is obtained following ampicillin hydrolysis in acidic medium. 
This fluorescent product was also obtained ,,,hen the method was 
applied to an ampicillin sample hydrolysed first with S-lactamase. 
The addition of formaldehyde was found to increase the yield of the 
fluorescent product. Jusko tentatively proposed that the fluorescent 
product was the diketopiperazine derivative.II. 
H 
Nt:!1~~H 
N 0 
H II 
Compound 11, however, was obtained in a high yield after hydrolysis 
of 6-epi-ampicillin in neutral aqueous solution in the presence of 
pyridine and acetic aCid54• Failure of ampicillin to produce 
the same product under the same conditions was attributed to steric 
hindrance54• Barbhaiya et al55 reported a fluorimetric assay for 
amoxicillin in which no formaldehyde was used. This method was found 
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tp be applicable to ampicillin. Nuoerous publications have appeared 
reporting fluorimetric assay. procedures based on the formation 
under different experimental conditions of fluorescent degradation 
products for the analysis of ~-lactam antibiotics having a side-chain 
containing an CL -amino group55-63. 
Several investigators21 ,64,65 reported that the fluorescent 
degradation product is 2-hydroxy-3-phenylpyrazine. Recently, 
Barbhaiya et al (1978)66 isolated the fluorescent degradation product 
obtained from a number of cephalosporins and penicillins containing 
the CL -amino group at the side chain. In all cases the product 
was shown by unambiguous synthesis to be 2-hydroxy-3-phenyl-6-
methjlpyrazine. 
Perrett67 studied the degradation of ampicillin in acidic 
medium using an amino acid analyser, and showed that several 
chromatographic peaks were obtained. A free sulphhydryl group 
containing compound was also formed. The formation of this compound 
parallels the increase in the area of a peak exhibiting maximum 
absorption at 440 nm. 
Blazsek-Bodo et al in 197868 reported that penicillamine was 
formed after alkaline hydrolysis of ampicillin and other penicillins. 
This has been made the basis of a potentiometric method for the 
determination of several penicillins including ampicillin. 
Cephalosporin C degradation 
The degradation studies of cephalosporin C played an important 
role in assigning the structure of this compound. These degradation 
studies were, in general, combinations of hydrogenation, 
desulphurization and hydrolysis. Scheme 3 shows most of the 
degradation pathways of cephalosporin C. 
Hydrolysis of cephalosporin C'in hot acid followed by oxidation 
of the neutral fraction with silver oxide yielded 0 -amino- 0 -carboxy-
valerylglycine I. Raney-nickel desulphurization at room temperature, 
followed by partial hydrolysis with acid degrades cephalosporin C 
to et - S -diaminopropionic acid II and D- et -amino-adipic acid69• 
Jeffery et al70 reported that a thiazole carboxylic acid III was 
obtained when cephalosp,<rin C was kept in neutral pyridine-water 
solution at 37°C, while imidazole -tetrahydropyridine IV was found 
to be produced when cephalosporin C was kept in water alone71 • 
Hydrolysis of cephalosporin C with Raney-nickel followed by 
hydrolysis with hot acid gave et -oxovaleric acid V72• Cephalosporin C 
lactone (Cephalosporin C ) VI was obtained after mild hydrolysis 
c 
of cephalosporin C with the liberation of acetic acid 'Ihich was 
isolated from strong acid solution. If the desulphurization product 
of cephalosporin C lactone (obtained after treatment of cephalosporin C 
lactone with RaneY-luckel) is treated with water, it gives an 
aminobutenolide VII, but if treated with acid it produces a 
hydroxybutenolide VIII69 • Two sulphur containing lactone compounds 
IX and X were obtained by hydrolysis of cephalosporin C in 1.25M 
hydrochloric acid at 1000C for one hour. Abraham and Newton69 
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RCONH[(i 
(i) H+ + 0 N~CHPCOCH3' 
(ii)Ag COOH ~ 
RCONHCH2COOH H 
2 ~H I (i) RaNi 
. ii)H+ 
RYi)S 
. ~I COOH 
III 
H j 
COO-
IV 
3'CHCOCOOH 
CH/ 3 
V 
~CH2-S-CH2D s~ . I 0, 
o OH' HO 0 
IX 
+ 
dCH2-S-C~O ° I ° 
o OH HO 0 
X 
Scheme 3 
c 
VI 
RaNi -H2 
+ . H . 
have suggested a mechanism by which these two compounds might be 
produced (see Scheme 4). They proposed that the carboxyl group of 
the hypothetical intermediate XI could lactonize with either the 
thiol group or the hydroxy group to give compound XII and XIII. 
Condensation of XII and XIII, as shown, would give compound IX, 
which undergoes S, y-elimination of the sulphur from the ketone form 
of the thiolactone ring of compound IX, followed by elimination of 
H2S and relactonization to give compound X. 
HSCH2'(CHzOR 
r COOH . 
XI· 
o OH HO 0 
XII XIII 
Scheme 4 
84 
f3 -lactern cleavage of cephalosporins 
Compared with the extensive studies on the degradation reactions 
of penicillins, relatively little work has been done on the 
degradation reactions of cephalosporins. Degradation studies are 
important as th~y may be associated with allergic reactions to these 
antibiotics. 
In spite of the structural similarity between the penicillins 
and cephalosporins, there are major differences in the way these 
compounds undergo B -lactam cleavage. When the f3 -lactern ring of 
penicillin is opened by mild alkaline hydrolysis, or with 
penicillinase, the corresponding penicilloate is mainly produced. 
This is a well-characterized and rela~ively stable compound69• 
Cephalosporins are readily attacked similarly by nucleophilic reagents 
and by cephalosporin.~-lactamases, but the initial corresponding 
degradatioI1 product, IIcephalosporoate", is unstable and rapidly 
fragments in aqueous solutions73 , Scheme 5. Recently, cephalosporoate 
RCONHO]S CH3 CH3 
o f\J COOH 
Penicillin 
OWor 
Penicillinase 
• 
RCONHnS't~: 
oAJi~-l~OOH 
Penicilloatc derivative 
RCONHr=(i. ,_~J-O __ 
o ~CH2-R 
RCONMIc
S 
HN H R/ OH 2-
eOOH COOH 
Cephalosporin· Unstable cephalosporoate 
Scheme 5 
like compounds were obtained under a variety of experimental 
condHions. Eggers et a174 'studied the'reaction of 
7-phenylacetar.1idoccphalosporanic acid (cepha.lorrun) with sodimn 
bcnzyloxide in benzyl alcohol. The final degradation product 
(the corresponding cephalosporoate) has lost the acetoxy group 
with opening of its B -lactam ring according to Scheme 6. 
5 
PhCH:zCONH,---() PhCH20Na 
~~. PhCH20H o CH2-R" , 
COOH 
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• 
Ph CH,coNHTi
Si 
PhCH200C N0CH2 
COONa 
Scheme 6 
Alkaline hydrolysis of cephalosporin C at room temperature has 
been shown to produce deacetyl-cephalosporin C in low yield. Higher 
yields, however, were obtained when cephalosporin C was treated with 
an acetyl esterase in neutral aqueous solution75• Acid hydrolysis 
of deacetylcephalosporin C at room temperature produced 
deacetylcephalosporin C lactone. The latter had been shown to 
produce from cephalosporin C itself69• Mild acid hydrolysis of 
deacetylcephalosporin C lactone opened the B-lactrun ring and 
yielded a relativel.y stable product which could be regarded as 
the corresponding cephalosporoate 69. Newton et a173 reported that 
the corresponding cephalosporoate was obtained following S-lact~~ase 
hydrolysis of cephalothin. These reactions are shown in Scheme 7. 
Hamilton-Miller et al76 reported that a labile compound with 
X max 230nm was obtained following aminolysis in weakly alkaline 
aqueous solutions of cephalosporins but not from deacetyl or deacetoxy-
cephalosporins. Hydrolysis with B -lactamase results in the 
formation of similar products from deacetyl cephalosporins and 
cephalosporins, but not from deacetoxycephalosporins. These 
degradation products were found to degrade further to cot1pounds 
tentatively identified as :penaldates and penamaldates. 
In order to shed more light on the identity of the above 
degradation products, Hamilton-Miller et al77 have followed the 
aminolysis and the enzymic hydrolysis of a number of cephalosporins 
having different substituents at the 3-position in ND3 and D20 by 
NMR and DV spectrophotometry. They concluded that the aminolysis 
of 7-n-butyramido-cephalosporanic acid is accompanied by 
expUlsion of the acetoxy group as acetate and the formation of an 
exo-methylene cot1pound (X 230nm) as a semistable intermediate. 
. max 
This compound was found to degrade further to give a penaldate 
(X 270nm). Similar results were obtained with cephalosporin C. 
max 
Aqueous aminolysis of 7-n-butyramidodeacetoxycephalosporanic 
acid and 7-n-butyramidodeacetylcephalosporanic acid, however, gave 
intermediate deacetoxy and deacetyl cephalosporoates. 
RCONHr-{S, 
i-~~CHPCOCH3 
COOH 
Cephalosporin 
Esterase 
RCONHrl)S 
AH~ .. -_0 Fragmentation products 
o OH CHPCOCH3 
COOH 
Cephalosporoic acid 
CH20H 
COOH 
Oeacetylce phalospori n 
o 0 
Cephalosporin lactone 
Scheme 7 
o 
Cephalosporoic acid lactone 
co 
co 
8 -lactamase hydrolysis of cephalosporin C and deacetylcephalosporin C 
also gave intermediate with· A . 230nm - a different result from 
max 
the aminolysis. The investigators speculated that enzymic hydrolysis 
could have converted the hydroxyl groups of deacetylcephalosporins 
into better leaving groups resulting in behaviour similar to that 
of cephalosporin C. Degradation pathways of the above study are 
depicted in Scheme 8. 
The enzymic hydrolysis of cephalosporin C, cephalothin, and 
cephaloridine was studied by Sabath and coworkers7~. They showed 
that opening of the S -lactam ring of these compounds by B -lactamase 
at pH 7 is accompanied by the spontaneous expulsion of acetate in 
case of cephalothin and cephalosporin C and the expulsion of 
pyridine from cephaloridine. Two equivalents of acid per mole·of 
antibiotic were produced. One equivalent is attributable to the 
8 -lactam ring hydrolysis while the other equivalent resulted from 
the liberation of acetic acid or pyridinium ion. By cOr.Jparison, 
Deacetoxycephalosporin C yielded only one equivalent of acid. 
Recently, Bundgaard42 sh?wed that during aminolysis and alkaline 
hydrolysis of cephaloridine, pyridine ion was found to be released 
quantitatively at exactly the same rate as the cleavage of the 
8 -lactam ring. 
Several reports have appeared recently which detail the 
degradation of cephalosporins. 
reviewed by Simmons in 197279. 
The degradation of cephalothin was 
80 Konecny et al reported the 
kinetics of the degradation of cephalosporin C in a wide pH range at 
250 C. Indelicato et a181 studied the substituent effects of various 
acyla~ido side chain moieties upon the alkaline hydrolysis of 
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cephalosporins and penicillins. The kinetics of aminolysis and alkaline 
hydrolysis of a series of cephalosporins in aqueous solution at 35°C 
were investigated by Bundgaard42• Yamana et a182 ,83 reported the 
kinetics and mechanisms of degradation of six therapeutically useful 
cephalosporins and other semi-synthetic cephalosporins in acidic, 
neutral, and alkaline aqueous solution. 
Recently, the hydrolysis of several cephalosporins in strongly 
acidic medium at 100°C was investigated by Bontchev et a184• They 
found that the hydrolysis proceeds with a high rate and results in 
the formation of definite products with low molecular weights. 
The lability of cephalosporins to ultra-violet· light was first 
reported by Demain in 196685 , who showed that cephalosporin Closes 
90% of its original biological activity in aqueous solution after 
being irradiated with UV light for 30 min. Maki et al 1977 86 
studied the mode of photodegradation of cephalosporins. They found 
that UV irradiation through a Pyrex filter of 3-cephem derivatives 
in alcohols caUses a novel photorearrangement, leading to thiazole 
derivatives, which involves incorporation of alcohols into an 
intermediate photoproduct. 
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Cephalexin 'and c~phradine degradation 
Cephalexin, 7- (D- CL -amino- CL -phenylac etamido)': 3-methyl-3-
cephem-4-carboxylic acid, is a new semi-synthetic cephalosporin. 
It is relatively acid stable and is completely absorbed following 
oral administration21 ,87. The antimicrobial spectrum of cephalexin 
is similar to that of cephalothin and cephaloridine but the latter 
antibiotics are poorly absorbed when administered orally and must 
therefore be given parenterally. Cephalexin which has the same side 
chain as ampicillin and has an unsubstituted methyl group at the 
3-position in the dihydrothiazine ring was found to be excreted 
h d " " b"l 88 unc ange 1n ur1ne or 1 e • 
Cephradine is similar to cephalexin having a 1,4-cyclohexadienyl 
group in place of the benzene ring. Its behaviour is similar to 
cephalexin. 
Elegant studies have recently been made of the degradation of 
cephalexin and cephradine by several investigators. Cohen et al 
in 197389 reported that degradation of cephradine in sodium carbonate 
solution at 5°C for one week affords the diketopiperazine 
(2- 6-(1,4-cyclohexadine-1-yl)-2,5-dioxo-3-piperazinyl) -5,6-dihydro-
5-methyl-2H-1,3-thiazine-4-carboxylic acid, sodium salt). 
H 
N S )~1)~H3 
H COONa 
Diketopiperazme derivative 
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Indelicato et a181,90studied the degradation of several 
cephalosporins in alkaline aqueous solutions at pH 10. They 
suggested that the degradation of cephalosporins having a side chain 
containing an a-amino group could take place by the intramolecular 
nucleophilic attack of the side chain a-amino group on the carbonyl 
carbon atom of the S-lactam ring. This would result in the formation 
of diketopiperazine type products. However, they were not able to 
isolate such degradation products from degraded aqueous solution 
of cephalexin or cephaloglycin.·, probably because degradation was 
performed at pH 10 where the major degradation pathway is a 
S-lactam hydrolysis. They succeeded, however, in isolating such 
products from a heated solution of cephalexin trichlorethyl and 
p-nitrobenzyl esters and cephaloglycin lactone in benzene under 
reflux overnight. Under the same conditions, ampicillin does not 
yield a similar cyclic product, but cyclic degradation products 
f . . 11· 64-66 d 6 . .. 11· h b t d54 rom amp~c~ ~n an -ep~-amp~c~ ~n ave een repor e • 
Extensive. kinetic and mechanistic studies of the degradation 
of cephalosporins in aqueous solutions have been reported by Yamana 
They were able to isolate a strongly fluorescent 
degradation product from the reaction mixture of cephalexin and 
cephaloglycin at.pH 8. This product was tentatively identified 
as the diketopiperazine derivative. They reported that at neutral 
pH, cephalexin, cephradine and cephaloglycin hydrolysis is mainly 
due to intramolecular nucleophilic attack of the side chain amino 
group on the S-lactam moiety which is superseded in importance 
at high pH by hydroxide-ion attack on the anionic antibiotics and at 
low pH by direct water catalyzed hydrolysis of the S-lactam ring • 
• 
Yamana et al83 suggested three possible kinetic ally indistinguishable 
mechanisms for ~amino groups participation in the S -lactam ring 
cleavage of these a-aminocephalosporins. These mechanisms are 
illustrated in Scheme 9. 
R-yHCONH-r---( 
NH I I 'CY)C-~ 
o 
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Scheme 9 
Mechanism(A) Intramolecular nucleophilic attack of the unprotonated 
side chain amino group on the B-lactam carbonyl moiety. 
Mechanism (B)'. Intramolecular general base catalysis by the amino 
group of the attack of water molecule on the S-lactam bond. 
Mechanism (C). Intramolecular general acid catalysis by the protonated 
amino group of the attack of hydroxide ion on the S-lnctam bond. 
Bundgaard91 0btained evidence of the involvement of mechanism (A) 
in the reaction of cephalexin from isolation of the diketopiperazine 
derivative, by observing that the side chain amino group was consumed 
during the degradation and from kinetic analysis of this amino group 
consumption. Bundgaard showed by primary amino gr9uP analysis that 
at pH 7 and 35°C, a 98% loss of the primary amino group occurs 
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indicating essentially complete degradation of cephalexin via the 
diketopiperazine derivative 11, whereas at pH above ~O only 32% 
of the cephalexin degrades by intramolecular aminolysis, the remainder 
degrading by hydrolysis of the S-lactam ring91. After degrading 
cephalexin in distilled water at pH 3, Dinner92 isolated 
3-hydroxy-4-methyl-2(5H)-thiophenone III and 3-formyl-3,6-dihydro-6-
phenyl-2,5(1H,4H)-pyrazinedione V. Bundgaard93 isolated and 
characterised a compound which is precipitated during the degradation 
of cephalexin in neutral aqueous solution as 3-aminomethylene-6-
phenyl-piperazine-2,5 dione IV. Bundgaard showed that this compound 
is a precursor of compound V. Barbhaiya et al66 reported that the 
fluorescent degradation product formed by treatment of cephalexin 
first with sodium hydroxide solution at room temperature and then, 
in pH 5 citrate buffer at 1000 C is 2-hydroxy-3-phenyl-6-methyl-
pyrazine VI. 84 Bontchev and Papazova found that a thiazine compound 
VII is formed following cephalexin hydrolysis in 12.5% sulphuric 
o 
acid solution at 100 C. 
Cephalexin degradation products are shown in Scheme 10. 
The diketopiperazine derivative of cephalexin compound 11 will be 
referred to as DKP' IIthroughout the text. 
The present investigation was carried out in order to evaluate 
the usefulness of d.p. polarography for the determination of 
cephalosporins and for studying their degradation in solution. 
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EXPERIMENTAL 
Equipment. Polarographic measurements were made with a PAR 174 
polarographic analyser (Princeton Applied Research Corporation). 
For differential pulse operation the forced drop time was 1 sec, 
-1 the scan rate 2 mV sec , and the pulse height 50 mY, except where 
otherwise indicated. Three-electrode operation was employed using 
a platinum counter electrode,· a dropping mercury working electrode 
(d.m.e) and a saturated calomel reference ·electrode. The water 
jacketed polarographic cell was kept at 250 C by passing water through 
the jacketed cell from a thermostatically controlled water bath. 
Solutions for polarography were deoxygenated with nitrogen gos wr~ch 
has previously been passed through a vanadium(II) scrubber. 
DV absorption spectrophotometric measurements were made with 
a Pye Unicam sp8000 and IR measurements were made with a Pye 
Unicam SP 200. A Baird-Atomic "Fluoricord" fluorimeter was used for 
the fluorimetric measurements. Potentiometric measurements were 
carried out with an Orion solid-state sulphide ion-selective electrode 
. (Model 94-16) and an expanded scale Radiometer PHM 64 research pH 
meter. Thin layer chromatography was done on precoated 0.25mm silica 
gel F254 aluminium sheets (Merck, Germany). 
Chemicals 
All chemicals were of analytical reagent grade except where 
otherwise indicated 
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Samples 
Samples of cephalothin, cephaloridine, cephalosporin C, 
deacetylcephalosporin C, 7-nminocephalosporanic acid (7-ACA), 
7-aminodeacetoxycephalosporanic acid (7-ADCA), cephoxazole, 
cephalonium, cefuroxime, cephalexin and penicillamine were 
obtained from Glaxo Operations (U.K.) Ltd. Samples of cephradine, 
ampicillin trihydrate and 2-hydroxy-3-phenyl-6-methylpyrazine 
were kindly provided by E.R. Squibb and Sons Ltd., Beecham 
Pharmaceutica~ Ltd. and Fisons Pharmaceuticals Ltd, respectively. 
Preparation of buffer solutions 
Britton-Robinson buffer solution. A stock solution of Britton-Robinson 
universal buffer solution (B.R. buffer) pH 1.9 composed of a mixture 
of boric acid, orthophosphoric acid and glacial acetic acid, all 
O.04M, was prepared; pH adjustment were made with O.2M sodium hydroxide 
solution as required. 
Phosphate buffer solution (pH 7.4) 
The phosphate buffer was prepared by adjusting a O.5M disodium 
hydrogen phosphate solution to pH 7.4 by addition of O.5M potassium 
dihydrogen phosphate solution. 
McIlvain's citrate-phosphate buffer solution 
A stock solution of citrate-phosphate buffer Was prepared by 
adjusting O.1M citric acid solution to the required pH with O.2M 
disodium hydrogen phosphate solution. 
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Sorensen's citrate buffer solution (pH 5) 
A stock solution of Sorensen's citrate buffer solution was prepared 
by adjusting the pH of O.1M disodium citrate (21-~{)g citric acid 
monohydrate"; dissolved in 200ml lM sodium hydroxide and made up to 
1 litre with distilled water) to pH 5 with O.1M sodium hydroxide. 
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EXPERIMENTAL TECHNIQUES 
A. D.P. POLAROGRAPHIC DETERMINATION OF CEPHALOSPORINS 
1. Preparation of stock solutions 
Except for 7-aminocephalosporanic acid (7-ACA) and 
7-aminodeacetoxycephalosporanic acid (7-ADCA), stock solutions of 
cephalothin, cephaloridine, cephalosporin C, deacetylcephalosporin 
C, cephoxazole, cefuroxime, cephalonium, cephalexin and 
cephradine were prepared in distilled water. Fresh solutions were 
'usually used before measurements. 7-ACA and 7-ADCA were dissolved 
in 2ml' of 0.2M sodium hydroxide solution and the resulting 
solutions were immediately made up to volume with pH 2 Britton-
Robinson buffer solution. Prolonged contact with sodium hydroxide 
solution caused extensive degradation, as indicated by the 
appearance of polarographic peaks of degradation products, and 
decrease in the height of the 7-ACA peak. 
2. Effect of pI! 
The effect of pH on the peak potentials and peak currents of the 
above cephalosporins was studied in B.R. buffer solution in the pH 
range 2-12. For each polarographic measurement, 1 ml of the freshly 
prepared stock solution containing 100 ~g/ml of the drug compound 
and 10 ml of the buffer solution at the required pH were placed in 
the polarographic cell. Oxygen-free nitrogen was passed through 
the solution for 5 min, the solution was then blanketed by an 
atmosphere of nitrogen whilst recording the d.p. polarograms. 
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3. Effect of mercury reservoir height 
The effect of the mercury reservoir height on the limiting 
current was studied in the d.c. mode at the optimum pH which gives 
the highest signal response ()lA/)l g). D.c. polarograms for each 
solution of the antibiotics (100)l&!ml) were obtained at various 
mercury reservoir heights. 
4. Construction of calibration graphs 
Calibration curves were prepared by successive syringe 
injections of concentrated solution of the antibiotic into a 
deoxygenated buffer solution at the optimum pH at 25°C. 
B. D.P. POLAROGRAPHIC STUDY OF THE DEGRADATION OF CEPHALOSPORIllS 
I. Degradation of cephalothin and cephaloridine 
The degradation of cephalothin (14O)lg/ml) and cephaloridine 
(100jJg/ml) was studied in B.R. buffer solution at pH 2 and 50oC. 
In the case of cephalothin the degradation was carried out directly 
in the polarographic cell, whereas the degradation of cephaloridine 
was carried out in a separate volumetric flask which was placed 
in a water bath at 500C. D.p. polarograms were obtained, for 
lOml of the degraded solution at suitable intervals. 
11. Degradation of cephalexin and cephradine 
1. Effect of temperature on the degradation of cephalexin and 
cephradine 
Initial degradation studies were carried out in phosphate buffer 
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solution at pH 7.4 and 37°C. Cephalexin and cephradine solutions 
(100vg/ml) were prepared by dissolving 25mg of the drug compound 
in 250ml of the above buffer. The flasks were then placed in a 
o 
water bath at 37 C. At suitable intervals, 10ml of the degraded 
solution was pipetted into the polaroeraphic celli solutions were 
deoxygenated with oxygen-free nitrogen for 10 minutes before 
recording the polarograms in the differential pulse mode at 250 C 
between 0.0 and -1.8v. 
When the effect of temperature was studied the flasks were 
placed in a water bath at the required temperature (60°C and 80°C) 
and d.p. polarograms were recorded as above. 
Throughout the degradation studies, a cephalexin concentration 
of 100vg/ml was used and d.p. polarograms were obtained at pH 7.4 
and 25°C irrespective of the temperature and the pH at which 
degradation was done except where otherwise indicated. 
2. Isolation of a sample of diketopiperazine 
A sample of diketopiperazine derivative was isolated from 
a degraded solution of cephalexin as follows: 
A solution of Ig cephalexin in 50ml of 0.3M aqueous phosphate 
buffer solution (pH 7.6) was kept at 35°C for 24 hours. A grey-white 
precipitate was formed, which was then filtered off through a 
Whatman No. 1 filter paper. The pH of the filtrate was brought to 
pH 2.5 with 5l'1 hydrochloric acid and extracted with b/o 50ml portions 
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of ethyl acetate. After being washed twice with water and subsequently 
dried over anhydrous sodium sulphate the combined ethyl acetate 
extracts were evaporated in a vacuum. oven at about 2'oC. The residue 
of evaporation was suspended in 25ml of boiling chloroform and 
filtered off. The residue was dried in a vacuum oven over phosphorus 
pentoxide for 24 hours. The identity of the product was confirmed 
by IR spectroph'otometry, fluorimetry, thin layer chromatography 
and melting point measurement. 
3. of diketo iperazine derivative 
a. Effect of mercury reservoir heights on the limiting current 
Diketopiperazine stock solution (1ml, 100 Vg/ml) was diluted to 
volume with phosphate buffer solution (pH 7.4) in a 10ml volumetric 
flask, mixed thoroughly, and transferred to the polarographic cell. 
The solution was deoxygenated for 10 minutes, and d.c. polarograms 
.,.- . 
were obtained. at various mercury reservoir heights at 25°C. 
b. Effect of temperature on the wave height of DKP 11 
The effect of temperature was studied using a diketopiperazine 
solution of 10 Vg/ml in phosphate buffer (pH 7.4). The measurements 
were carried out at 25, 30, 35, 40 and 45°C. Because of the lability 
of DKP 11, a fresh solution was used each time. 
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c. Cdnstruction of a calibration graph for the determination of DKP 11 
Into the clean dry polarographic cell, 10ml of phosphate buffer 
solution (pH 7.4) was placed. The solution was deoxygenated for 10 
minutes, and a blank was recorded. A calibration graph was then 
obtained by successive syringe injection of 0.25ml portions of 
concentrated solution of diketopiperazine (0.5mg/ml). After each 
injection, the solution was deoxygenated for 2 minutes (to ensure 
complete mixing) before recording the d.p. polarogram between 
o 
-0.7V and -1.1V at 25 C. 
d. Degradation of diketopiperazine in phosphate buffer solution 
A solution of lOmg diketopiperazine in 100ml phosphate buffer 
(pH 7.4) was prepared in a lOOml volumetric flask. The flask 
was placed in a water bath at 37°C. Aliquots (1Oml) of the 
degraded solution were drawn at suitable intervals, placed in the 
polarographic cell and deoxygenated for 10 minutes before recording 
the d.p. polarogram at 250 C between 0.0 and -1.6v. 
4. Isolation of a sample of 2-hydroxy-3-phenyl-6-methylpyrazine 
Cephalexin (0.5g) in distilled water (50ml) was treated with 
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sodium hydroxide solution (25ml, lM) for 10 minutes at room temperature. 
Hydrochloric acid (25ml, lM) was then added followed by Szrensen's 
citrate buffer solution (150ml, pH 5) containing formaldehyde (1% v/v) 
The mixture was then heated at 1000 C for 30 minutes, cooled and 
extracted repeatedly with ethyl acetate. The combined ethyl acetate 
extracts were then evaporated, and the residue was crystallized 
from ethyl acetate. For comparison purposes, d.p. polarograms and UV 
spectra, were obtained for the prepared sample and a sample of the 
pure compound, also thin layer chromatography on silica gel F254 
plate for the two samples were compared, the plate was eluted with 
acetone-chloroforme (1:1 v/v). 
~--------------------------------...... 
5. Effect of initial cephalexin concentration 
The effect of initial cephalexin concentration on the degradation 
process was studied using cephalexin solutions of 5, 100~ml and 
5mg/ml all in phosphate buffer at pH 7.4 at 37°C and 800e. 
Polarographic measurements were carried out at 25°C as described 
above. 
6. Effect of the presence of hydrogen sulphide and molecular oxygen 
in the degraded solution of cephalexin. 
In this set of experiments, the degradation of cephalexin was 
carried out in a gas wash bottle whilst passing a slow stream of 
nitrogen (or air when the effect of dissolved oxygen was being 
studied) through the solution. The nitrogen or air was presaturated 
with water in a second wash bottle, both bottles being contained in 
a water bath at the required degradation temperature. The hydrogen 
sulphide evolved was stripped from the nitrogen or air by passing it 
through a stripping solution (10-~ cadmium nitrate solution or lM 
sodium hydroxide solution). D.p. polarographic measurements were 
carried out using 10ml of the degraded solution at suitable 
intervals. When the amount of hydrogen sulphide was being 
determined, polarographic measurements were made using a separate 
solution of cephalexin which was prepared and kept under the same 
experimental conditions. 
7. Determination of hydrogen sulphide evolved during cephalexin 
degradation. 
Two approaches for the determination of hydrogen sulphide were 
examined: 
105 
a. Potentiometric determination of hydrogen sulphide 
Preparation of sodium sulphide standard solution: 
Due to the hygroscopic nature of sodium sulphide, it is not 
possible to prepare solutions of exact molarity, and it was necessary 
to standardise these solutions. All solutions used in this study 
were prepared in tri-distilled water which was boiled, for about 
one hour and cooled under a stream of oxygen-free nitrogen. An 
approximately O.lM solution of sodium sulphide prepared in 0.2M 
sodium hydroxide solution was standardised' against 0.1H silver 
nitrate standard solution using a sulphide ion-selective electrode. 
The molarity of silver nitrate solution was confirmed by a routine 
standardisation procedure 
and potassium chromate as 
using standard sodium chloride solution 
• 
an indicator (Hohr titration) 94. 
Recovery of hydrogen sulphide from a standard sodium sulphide solution 
An aliquot (0.2ml) of standard sodium sulphide solution 
(0.0955M) was diluted to 50ml with phosphate buffer solution (pH 7.4), 
the solution was transferred to a gas Wash bottle being placed in a 
o 
water bath at 37 C. A slow stream of nitrogen which had previously 
been saturated with water Was passed through the solution for I hour. 
The hydrogen sulphide was absorbed from the ensuing nitrogen stream 
in 50ml of lM sodium hydroxide solution. The sodium sulphide formed 
was then directly titrated against a 10-2u silver nitrate standard 
solution using a sulphide ion-selective electrode. 
b. Polarographic determination of hydrogen sulphide 
Ciirate buffer solution' (EH 4.6)_., 
Citrate buffer solution was prepared by dissolving 52.1g citric 
acid and 28.1g potassium hydroxide in 500ml of distilled water. 
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Sodium sulphide solution 
From a freshly prepared and standardised sodium sulphide solution 
(0.0952M), a 2ml aliquot was diluted to 100ml with 0.2M sodium 
hydroxide solution. 
Cadmium nitrate solution 
A standard solution of cadmium nitrate (1 x 10-~1) was prepared 
by dissolving 0.0746g in 250ml of distilled water. 
Construction of a calibration graph 
Into a clean dry polarographic cell, 10.Oml of cadmium nitrate 
standard solution (1 x 10-~) and 10.Oml of citrate buffer solution 
,;ere placed. The solution was deoxygenated for 10 minutes and a d.p. 
polarogram was obtained between -0.4v and -0.8v at 25°C. A 
calibration graph was obtained by successive syringe injections of 
sodium sulphide standard solution (1.9 x 10-3M) into the 
deoxygenated solution (O.5ml was injected each time). The solution 
was deoxygenated for a further 30sec after each injection before 
o 
recording the d.p. polarograms at 25 C. 
Hydrogen sulphide evolved during the degradation of 
cephalexin was absorbed in lO.OmI·, cadmium nitrate standard solution 
(1 x 10-3M). After suitable intervals, the absorbing solution was 
transferred to the dry polarographic cell, 10.0 ml of previously 
deoxygenated citrate buffer was added and the polarogram was recorded 
as above. The concentration of sulphide was obtained by comparing 
the cadmium peak hQight with those obtained for standards. 
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When the potentiometric method was used, the hydrogen sulphide 
was absorbed in ;!:M sodium hydroxide solution,. and .the sodium sulphide 
formed was immediately titrated against standard solution of silver 
nitrate. This method, however, was used infrequently and at high 
sulphide concentrations only. 
8. Effect of pH on the degradation of cephalexin 
The effect of pH has been studied in citrate-phosphate buffer 
solution at pH 3 (the buffer was prepared by adjusting O.lM citric 
acid solution with 0.5M disodium hydrogen phosphate to pH 3.0) and 
in.disodium hydrogen phosphate-potassium dihydrogen phosphate buffer 
solution at pH 8.5 and 10. In the latter case, the pH of the 
phosphate buffer (pH 7.4) was adjusted to pH 10 by the addition 
of 0.2M of sodium hydroxide solution. The degradation was studied 
also in distilled water without buffering ·and in O.lM sodium hydroxide 
solution. 
III Com arative de radation studies of acid 
7-ACA) and 
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The degradation of 7-ACA and 7-ADCA was studied in O.lM sodium 
hydroxide solution at 250 C by d.p. polarography and UV spectrophotometry. 
Procedure. Solutions of 7-ACA and 7-ADCA (100 and 86 ~g/ml, respectively) 
were prepared in O.lM sodium hydroxide solutions in 50ml volumetric 
flasks. o The flasks were placed in a water bath at 25 C. After 
suitable intervals,an aliquot(2ml) of the degraded solution was 
transferred to the polarographic cell which contains 10ml of previously 
deoxygenated B.R. buffer solution pH 1.9 (final pH 2.4). The solution 
was then deoxygenated for a further 2 minutes before recording 
the polarogram in the d.p. mode between 0.0 and -1.2V. 
IN absorption measurements were carried out by diluting1'ml 
of the degraded solution to 6ml with O.lM sodium hydroxide. The 
spectrum was recorded using lcm silica cells against sodium hydroxide 
solution (0.1M) as reference. 
Determination of the amount of hydrogen sulphide evolved during the 
degradation of 7-ACA and 7-ADCA 
Procedure. Solutions of 7-ACA and 7-ADCA were prepared by dissolving 
10mg of each compound in 100ml of 0.1M sodium hydroxide solution. 
The solutions were placed ,in gas wash bottles being placed in a water 
o bath at 25 C. The solutions were continuously flushed with a slow 
stream of nitrogen gas which had previously been saturated with 
water. The hydrogen sulphide was stripped from the nitrogen gas 
by absorbing it in 10.0 ml of cadmium nitrate standard solution 
(1 x 10-\1). After 4.5 hours, each solution was acidified with 
2ml of concentrated hydrochloric acid, and the hydrogen sulphide was 
driven out with nitrogen for a further 30 minutes. The cadmium 
nitrate solution was transferred to the polarographic cell, and 10ml 
of citrate buffer (pH 4.6) was added. The solution was deoxygenated 
o for 5 minutes and a d.p. polarogram was obtained at 25 C between 
-0.4v and -0.8v. The concentration of sulphide was obtained by 
comparing the cadmium peak height with those of standards. 
C. D.P. POLAROGRAPHIC DETERMINATION OF CEPHALEXIN 
1. Recommended procedure. 
Into 10ml calibrated flasks add aliquots (<;5ml) of neutral 
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cephalexin solution (standard, or sample,) containing less than 30 ~g 
of cephalexin and dilute the· solution to 10ml with pH 7.4 phosphate 
buffer. Place the loosely-stoppered flasks in a boiling water bath 
for 1 hour, cool and transfer the solution to the polarographic cell. 
Deoxygenate the sol·ution for 5 minutes and obtain d.p. polarograms 
between -1.1 and -1.4v at 250C. 
The reproducibility of the method was checked by repeating the 
experiment ten times at the 2 ~g/ml level. On one occasion, the 
dissolved oxygen was removed from the solution by passing a stream 
of oxygen-free nitrogen through the solution for 15 minutes before 
the hydrolysis step. 
2. Effect of hydrolysis time on the .. peak height at -1.26v 
In each of four 10ml calibrated flasks, cephalexin solution 
(0.5ml, 100~g/ml)was diluted to volume with phosphate buffer solution 
(pH 7.4). The loosely-stoppered flasks were placed in a boiling 
water bath for various periods of time (45, 60, 75 and 90 minutes). 
110 
The contents of each flask was cooled, transferred to the polarographic 
cell and deoxygenated for 5 minutes before recording the d.p. polarogram 
Q between -1.1 and -1.4V at 25 C. 
3. Effect of standing time at 250 C on the peak height at -1.26v 
Cephalexin solution hydrolysed for Ihour as above was left 
• 0 in the polarographic cell at 25 C for 2.5 hours and a d.p. polarogram 
was recorded again as described above. 
4. Effect of pH on the peak potential 
Cephalexin in pH 7.4 phosphate buffer solution C50ml, 10 \.Ig/ml) 
was hydrolys'ed for 1 hour at 100oC, and d.p. polarograms at various 
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pH values were obtained after adjusting the solution pH to the required 
value with lM sodium hydroxide and lM phosphoric acid solutions. 
5. reservoir hei ht on the d.c. limitin current 
D.c. polarograms were obtained for the hydrolysed cephalexin 
solution (10~ml) at various mercury reservoir height, at 25°C. 
The effect of raising the temperature on the d.c. wave height was 
also studied using the same solution. 
6. Hydrolysis of cephalexin to form 2-hydroxy-3-phenyl-6-methylpyrazine. 
Procedure. To a 10ml volumetric flask an aliquot (typically lml) 
of cephalexin stock solution (10 \.Ig/ml) and 0.5ml of 2M sodium 
hydroxide solution were added and left for 10 minutes at room 
temperature. Then 0.5ml of 2M hydrochloric acid solution and·3ml 
of citrate buffer pH 5 (0.2M citric acid adjusted to pH 5 with lM 
sodium hydroxide solution) were added. The flask was loosely 
stoppered and heated in a boiling water bath for 30 minutes, cooled 
and diluted to 10ml with phosphate buffer (pH 8.5). The solution 
was transferred to the polarographic cell and deoxygenated for 10 
minutes. A d.p. polarogram was obtained between -0.85 and -1.1V. 
The reproduci bi li ty of the method was checked at 1 and 5 \.I g/ml 
of cephalexin in the measured solution by repeating the experiment 
several times. Attempts to improve 
were made by including formaldehyde 
the reliability of the method 
60 (tYo v/v) as a catalyst , 
increasing the heating time to 60 minutes and using different 
concentrations of sodium hydroxide. 
Isolation of a sample of 2,4-dinitrophenylhydrazone of the carbonyl 
compound responsible for d.p. peak at -1.26v. 
Procedure. Cephalexin (0.5g) was dissolved in 100ml of pH 8.5 
phosphate buffer and the solution was heated in a water bath at 
800 c for 12 hours whilst continuously flushing the hydrogen sulphide 
formed from the solution by means of a stream of nitrogen gas. 
After cooling the solution, the grey-white precipitate of 
3-aminomethylene-6-phenyl-Piperazine-2,5-dione93 was filtered off, 
and a saturated solution of 2,4-dinitrophenylhydrazine in methanol/ 
concentrated hydrochloric acid (10:1 v/v) was added to the filtrate. 
The solution was heated to 600c for 1 minute and then was allowed to' 
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cool to room temperature. The 2,4-dinitrophenylhydrazone was filtered 
off and was purified on a preparative silica gel TLC plate eluting 
with 3:1 chloroform-methanol. The main compound had an Rf value of 
0.35. The compound was obtained as a solid after extraction into 
ethanol. 
D. D.P. POLAROGRAPHIC STUDY OF TIlE DEGRADATION OF AMPICILLIN 
Methods 
Degradation studies were carried out as described previously 
for cephalexin degradation. Degradation solutions were contained 
in a suitable wash gas bottles in a water bath at the required 
temperature. Nitrogen gas, previously saturated with water, was 
passed through the solution throughout the degradation and the evolution' 
of hydrogen sulphide was tested for by passing the ensuing nitrogen gas 
through a standard solution of cadmium nitrate (10-1M). When it 
was required to study the effect of molecular oxygen on the 
~egradation the nitrogen. was replaced by air. 
Degradation studies were carried out in pH 7.4 phosphate buffer 
solution at .37°e and in pH 2.5, 8.5 McIlvain's citrate-phosphate 
buffer solutions. The effect of temperature on the degradation 
process was studied at 37°e, 600 e and 800 e in McIlvain's buffer at 
pH 2.5. 
In all cases, 100~g/ml ampicillin trihydrate was used 
(85.5 ~g/ml ampicillin as free acid). Spectrophotometric measurements 
were carried out using 1 cm silica cells, and the degraded solutions 
were cooled before recording spectra. 
Polarographic determination of penicillamine 
Penicillamine gives a well defined anodic wave at -0.14v 
in citrate-phosphate buffer pH 2.5. The half wave potential was 
found to be concentration dependent. 
a. - Effect of mercury reservoir height on the d.c. anodic wave of 
penicillamine 
Into the polarographic cell, 10ml of citrate-phosphate buffer 
solution pH 2.5 and 2ml of penicillamine solution (100~g/ml) were 
placed and deoxygenated for 10 minutes. Polarograms were recorded 
in the d.c. mode at 25°C and various mercury reservoir heights. 
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b. - Effect of temperature 
The effect of temperature on the d.c. anodic wave was studied 
using the above solution. The temperature of the polarographed 
solution was adjusted to the required temperature (25, 30, 350 C) 
by passing water from the thermostatically controlled water bath 
through the jacketed polarographic cell. 
c. Effect of pH on the half-wave potential, d.c. limiting current, 
d.p. peak potential and peak height of penicillamine. 
The polarographic behaviour of penicillamine in the pH range 
2-12 was studied in B.R. buffer solutions; the pH was adjusted to 
the required value by adding 0.2M sodium hydroxide solution. For 
each polarographic ru~, 10ml of the buffer solution (at the required 
pH value) and 2ml of penicillamine stock'solution (100 ~g/ml) were 
placed in the polarographic cell, and deoxygenated for 10 minutes. 
The solution was blanketed by an atmosphere of nitrogen whilst the 
polarograms were recorded. Polarogra~s in the d.c. and d.p. modes 
were obtained for each solution at 25°C. 
d. Concentration effect 
The concentration effect was studied in citrate-phosphate 
buffer at pH 2.5 and 250 C. Two calibration graphs were obtained 
in the concentration ranges 1.96 - 21.8 ~g/ml and 9 - 44.4 ~g/ml. 
Polarographic determination of 2-hydroxy-3-phenyl-6-methyl-pyrazine 
The polarographic behaviour of 2-hydroxy-3-phenyl-6-methyl-
pyrazine was studied as above, and calibration graphs were obtained 
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in citrate-phosphate buffer solutions at pH 2.5 and 250 C in the 
concentration ranges 1.7 - 8.38 ~g/ml and 3.5 - 18.6 ~g/ml. 
The calibration graphs for this compound and also for 
penicillamine were used for the determination of the amounts of 
penicillamine and 2-hydroxy-3-phenyl-6-methylpyrazine formed 
during the degradation of ampicillin. 
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RESULTS 
A. D.P. POLAROGRAPHIC DETERMINATION OF CEPHALOSPORINS 
Cephalothin, cephalosporin C, 7-~inocephalosporanic acid, 
cephoxazole and deacetylcephalosporin C which have a substituted 
3-methyl group behave quite similarly in B.R. buffer at pH 2. All 
of them exhibit a well defined polarographic peak at about -1V 
at pH 2-4. This peak was found to disappear at pH values higher 
than 4. The extent of the change of the half Wave potential with 
pH is consistent with the electrode reaction being irreversible. 
Also the size of the peak is dependent on pH and is at a maximum 
at pH 2. Analysis of d.c. polarograms with respect to changes in 
the limiting current >nth mercury reservoir height indicated diffusion 
control. The half-wave potentials were found to be concentration 
dependent, which gives further evidence on the irreversibility of the 
electrode reaction. 
Cephaloridine exhibits blo polarographic reduction peaks in the 
pH range 2-12, but only the first reduction peak has been used for 
analytical purposes here. The-peak potential of the (main) first 
peak is (-0.79 - 0.068 pH) V in the pH range 2-9. The size of the 
first peak is pH dependeni;. and is at maximum at pH 2. Nevertheless, 
the calibration curve was obtained at pH 4 to reduce the interference 
effect of the buffer. At pH 8 a polarographic maximum of the first 
kind was observed on the d.c. polarogram which was not affected by 
the addition of the maximum suppressor Triton X-100. 
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Cephalonium shows three polarographic peaks in B.R. buffer. 
The second and third peaks disappear at pH values higher than 
8. The peak potential of the first peak is ~(~.51 - 0.069 pH)V 
in the pH range 2-9. This peak, which is twice the height of the 
other two, was used for analytical purposes. 
Cefuroxime gives two polarographic peaks: the first peak is 
about twice the height of the second peak. The second peak at -1.02V 
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(pH 2.5) disappears at pH values higher than 5. This behaviour is 
similar to that observed with other cephalosporins with a substituted 
3-methyl group. This is believed to be due to the reductive elimination 
of the -DOCNH~roup at the 3-position. The first peak, however, was 
used for the ·determination of cefuroxime in B.R. buffer pH 2.5. 
7-Aminodeacetoxycephalosporanic acid (7-ADCA) does not give 
a polarographic peak, but several of its degradation products do. 
This had been observed when the compound was first dissolved in 
sodi~~ hydroxide and then B.R. buffer pH 2 added. Cephalexin and 
cepbradine which have unsubstituted methyl groups on the 3-position 
were found not to give polarographic Wave at the dropping mercury 
electrode. 
Results obtained for the cephalosporins studied are 
summarised in Table 1, and typical differential pulse polarograms 
obtained in producing calibration curve for each compound at the 
optimum pH are shown in the Appendix together with graphs showing 
the effect of pH on the peak potentials (full lines) and peak heights 
(broken lines) for most of the studied compounds. 
Calibration curves (typically 0-3pg/ml) were rectilinear in all 
cases. 
Table 1. Data obtained for the cephalosporins studied 
Name Optimum Position of Position of Linear range 
pH d.p. peaks peak used (Ilg/ml) 
(Volt) for 
analysis 
(Volt) . 
Cephalothin 2 -1.0 -1.0 0.42 - 2.36 
Cephaloridine 2 -1.0 -1.0 0.2 - 1.82 
Deaeetyl-
cephalosporin C 2 -0·99 -0.99 0.39 - 1.48 
Cephcxazole 2 -0·95 -0.95 0.1 - 1·33 
7-ACA 2 -0·99 -0.99 0.1 - 0.86 
Cephaloridine 4 -1.06, -1.2c ~ 0.15 - 3·32 
Cephalonium 3 -0.72, -1.0 -0.72 0.05 - 0.38 
-1.12 
Cefuroxime 2.5 -0.39,-1.02 -0.39 0.1 - 1.08 
Cephalexin 2 - 12 
Cephradine 2 - 12 
. 
B. D.P. POLAROGRAPHIC STUDY OF THE DEGRADATION OF CEPHALOSPORINS 
I. Degradation of cephalothin and cephaloridine 
The applicability of d.p.p. to degradation and stability 
testing studies has been examined. Preliminary hydrolysis studies 
of cephalothin and cephaloridine showed that heating of these 
antibiotics in aqueous B.R. buffer solution at pH 2 and 500 C and 
37°C respectively, results in the decrease of the characteristic peak 
height at about -1V and the appearance of small peaks at less. 
negative potential. D.p. polarograms showing the d~gradation of 
cephalothin and cephaloridine are depicted in Fig. 1 and 2. 
Previous investigators42 ,73,79 reported that the opening of 
the 8 -lactam ring of cephalothin and cephaloridine following acid, 
alkaline or enzymatic hydrolysis is accompanied by the expulsion 
of the acetoxy and the pyridine side chain on the 3-position to 
form the corresponding polarographically inactive cephalosporoate 
lactone26 • This will explain the decrease in the d.p. peak height 
with heating time, as the presence of the substituted methyl grpup 
on the 3-position is the essential requirement for polarographic 
activity of these compounds in the absence of other reducible group 
in the molecule. 
11. Degradation of cephalexin and cephradine 
The initial degradation studies of cephalexin and cephradine 
(100 ~g/ml) were made in phosphate buffer solutions (pH 7.4) and 
37°C without flushing the solution with nitrogen. The degradation 
of these compounds was followed over a period of 340 hours. D.p.p. 
119 
QCH,CONHO) o N CH2-OCOCH3 
COOH 
CEPHALOTHIN ( i ) (\ 
(ii) 1\ 
l-
S", I n z (i iil w 0:: 0:: ,(\ ::l (iV) (J 
.YJ 
(V) 
,) 
I 
00 -04V -O·SV -1.2 V 
Potential (Volt vs.S.C.E.) 
Fig. 1. D.p. polarograms showing degradation of 1~g ml-1 solution 
of cephalothin in B-R buffer at pH 2 at 50oC. Measurement 
time (i) 0.5 (H) 2.0, (iii) 2.5 (iv) 4.5, (v) 18.5 hours. 
Degradation was carried out in the polarographic cell and 
the polarograms were obtained at 500 C 
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D.p. polarograms showing degradation of lOO~g ml-1 of 
solution of cephaloridine in B-R buffer atpH 2 at 37°C 
Measurement time: (i) 0, (ii) 17.5, (iii) 27, (iv) 48, 
(v) 96 hours 
Polarogra~s were obtained at25°C. 
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curves showing part of the degradation of cephalexin are shown in 
Fig. 3. The first peak appeared at -0.56v is due to hydrogen 
sulphide. The large peak at -0.9V is due to diketopiperazine 
derivative (DKP 11). The appearance of the other two pew<s at -0.78V 
and -1.26v will be discussed later. Cephr,adine as expected, was 
found to behave in the same manner. 
The changes in the pewc heights of cephalexin and cephradine 
degradation products with time are illustrated in Tables 2,3 
and Figs. 4, 5. 
A sample of the diketopiperazine derivative was isolated from 
a degraded solution of cephalexin as described by Bundgaard91 • 
The product had the following characteristics: 
IR (kBr) \) : 3150, 1770, 1720, 1675, 1450, 1320, 1070, 725 and 
max 
695 cm-1 , spectrofluorimetric excitation maximum at 360nrn and 
emission maximum at 433 nm (both uncorrected, in 0.1M sodium 
bicarbonate), thin layer chromatographic analysis on Meric silica 
gel F254 plates with solvent system water-glacial acetic acid-acetone-
ethyl acetate (1:2:2:5 v/v) gives Rf value of 0.61t. These results 
are in accord with the findings of BUndgaard91 • The melting point 
(145 - 148°c) was less than that quoted 160-162oC. However, the 
compound gives only one d.p. polarographic peak at -0.9V in phosphate 
buffer pH 7.4. Evidence that this polarographic wave is diffusion 
controlled was obtained from studying the effect of mercury pressure 
and temperature on the d.c. wave height. A straight line which passes 
through the origin was obtained when the wave height (~A) was plotted 
against the square root of the mercury reservoir ,height (corrected for 
back-pressure). Also a temperature coefficient typically of 2% 
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cephalexin in phosphate buffer at pH 7.4 at 370 C. 
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-Table 2. Changes of d.p. peak heights of cephalexin degradation 
roducts with heatin time-at 70C in hos hate buffer 
solution pH 7. 
. Time/hrs Peak height /llA 
Peak at Peak at Peak at Peak at 
-0.56v -0.78v -0.9V -1.26v 
- . 
0.0 0.0 0.0 0.0 0.0 
.. 
2.0 0.0 0.0 2.0 0.0 
5.0 0.1 0.0 4.3 0.0 
7.0 0.15 0.0 5.4 0.1 
14.75 0.18 0.0 5.3 0.4 
, 
22.00 0.80 0.0 5.4 1.3 
24.25 1.00 0.0 4.9 1.6 
26.25 1.40 0.0 4.7 1.7 
28.00 1.55 0.0 4.~ 1.9 
31.00 1.70 0.05 4.2 1.95 
46.50 2.50 0.10 2.8 2.10 
48.50 2.60 0.12 2.75 2.20 
50·50 2.50 0.15 2.60 2.20 
54.00 1.90 0.20 2.25 2.10 
70.00 2.90 0.45 1·50 1.96 
75·50 2.60 0.70 0.85 1.96 
94.00 2.35 0.75 0.45 1.65 
102.00 2.25 0.90 0.40 1.62 
121.00 2.25 1.10 0.25 1.50 
144.00 2.00 1.20 0.12 1.45 
168.00 1.90 1.30 0.01 1.35 
190.50 1.60 1.35 0.00 1·35 
214.50 1.30 1.35 0.00 1.25 
334.00 0.70 1.50 0.00 1.15 
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Table 3. 
Time/hrs 
0.5 
2.5 
4.'7 
7.3 
22.0 
24.7 
26.1 
28.5 
30.8 
46.5 
48.5 
51.4 
53.8 
70.4 
75.4 
94.4 
102.3 
119.7 
143.4 
164.7 
189.0 
214.0 
334.0 
Changes of d.p. peak heights of cephradine degradation 
products with heating time at 37°C in phosphate buffer 
solution pH 7.4 
Peak height /uA 
Peak at Peak at Peak at Peak at 
-0.56v -0.78v -0.9V -1.26v 
0.0 0.0 0.0 0.0 
0.0 0.0 0.6 0.0 
0.;1 0.0 1.8 0.0 
0.2 0.0 4.8 0.0 
1.6 0.0 4.8 1.2 
1.85 0.0 4.9 1.4 
2.0 0.0 4.9 1.7 
2.2 0.0 4.5 1.7 
2.4 0.0 4.0 1.8 
3.1 0.0 2.6 2.0 
3.0 0.1 2.3 1.9 
3.1 0.1 2.15 2.15 
3.1 0.1 2.0 1.9 
3.5 0.2 1.2 1.7 
3.2 0·3 0.8 1.5 
3.1 0.35 0.4 1.3 
3.0 0.45 0.35 1.25 
3.0 0.50 0.20 1.0 
2.7 0.65 0.1 1.0 
2.4 0.70 0.0 . 0.9 
2.3 0.75 0.0 0.75 
2.0 0.70 0.0 0.90 
1.4 0.70 0.0 0.80 
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was obtained. The half-wave potential was found to be dependent 
on concentration and slightly shifted to more negative potentiala 
as the concentration of DKP II increased. D.p. polarograms 
obtained for DKP I1 in phosphate buffer solution pH 7.4 at 25°C 
are shown in Fig. 6. A rectilinear calibration graph obtained 
over the concentration range 12 - 84~g ml-1 is shown in Fig. 7. 
This calibration curve was then used to determine the amounts of 
DKP II formed in degraded solutions of cephalexin. 
The degradation of DKP I1 has also been followed in phosphate 
buffer pH 7.4 and 37°C. Similar polarographic Patterns as those 
observed in the degradation of the parent compound (cephalexin) 
were obtained. A plot of peak heights of DKP II and its degradation 
products versus time is shown in Fig. 8. 
The degradations of cephalexin and cephradine under the 
above experimental conditions were found to follow an apparent 
first-order reaction with a rate constant of 0.2 and 0.43 hr-1 
respectively. The rate constants were obtained by plotting the 
logarithm of peak heights (~A) of DKP II (formed in the early 
stages of degradation) versus measurement time (hours). 
The degradation of DKP II was also found to follow a first-
order reaction with -1 a rate constant of 0.025 hr ,regardless of 
whether the degradation was followed for a pure sample of DKP 1I or 
for DKP I1 formed during the degradation of cephalexin. An 
abrupt increase in the rate constant has been observed between 70-
75 hours; then the degradation of DKP 11 started to follow exactly 
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Fig. 6. D.p. polarograms obtained for DKP 11 in phosphate buffer solution at 
pH 7.4 and 25°C. 
(i) OJ (ii) 12.2j(iii)23.8j (iv) 34.9j (v) 45.5; (vi) 55.6; 
(vii) 65.2j (viii~ 74.5; (ix) 83.3 ~g ml-1 
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Fig. 7. Calibration graph obtained for DKP II in phosphate buffer 
solution pH 7.4 at 25°C 
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the same rate constant as previously. A similar result was obtained 
for the degradation of DKP derived from cephradine but the rate 
-1 
constant in this case was 0.03 hr • The results are illustrated 
The effect of various factors on the degradation of cephalexin 
was then studied. First, the effect of increasing the temperature 
was monitored. 
At 600 e the swne pattern was obtained, but the degradation 
is faster.. The DKP II peak attains its maximum value after two 
hours and disappears completely in 22 hours. Also, a high yield 
of the compound responsible for the peak at -1.26v was obtained. 
The maximum yield was about double that obtained at 37°e (compare 
Fig. 4 and Fig. 10) • 
At 800 e DKP II was formed and degraded within 2.5 hours and 
the peak at -1.26v ,IaS about five times larger than any other peak 
present, Fig. 11. The peak at -0.78v disappeared after 54 hours 
degradation. In addition to the peak at -0.16v another peak 
appeared at -O.96V later in the degradation after DKP II had 
degraded. The compound responsible for this latter peak was 
identified by t.l.c., UV spectrophotometry and by comparison with 
polarograms obtained with a s~mple of the pure compound as being 
due to 2-hydroxy-3-phenyl-6-rnethylpyrazine(VI); this compound had 
66 been isolated from degraded cephalexin solutions by Barbhaiya et al 
and identified by una~biguous synthesis. Ad .p. polari)gra~ 
obtained for a sa'l1ple of 2-hydroxy-3-phenyl-6-rnethylpyrazine isolated 
from degraded solution of cephalexin as described by Barbhaiya et a166 
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Fig. 9. Plot of logarithm of DKP 11 peak height. ( ~A) versus 
measurements time (hours) obtained for the degradation 
of pure sample of DKP 11 ........ , degraded cephalexin solution 0----0 
and 0---0 degraded cephradine solution all in phosphate 
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Degradation of cephalexin (lOO~g/ml) in O.5M phosphate 
buffer at pH 7.4 and 80°C. Peak potentials: 
(i) -O.9V (DKP 11), (ii) -1.z6v, (iii) -O.56V (hydrogen sulphide), 
(iv) -o.16v I (v) -O.78v and (vi) -O.96V 
(Z-hydroxy-3-phenyl-6-methylpyrazine) 
is shown in Fig. 12. In Fig. 13, UV spectra of the prepared 
sample and a pure sample of this compound are compared. 
The effect of the initial cephalexin concentration was studied 
next. Polarograms obtained for 5 ~g/ml solutions degraded at 37°C 
were of similar pattern to those for lOO~g/ml solutions degraded 
at 37°C or 80oc. When 5 mg/ml solutions were degraded at 800 c 
however, the peak at -1.26v disappeared and a peak appeared at 
-1.44v (irrespective of the concentration at which the polarography 
was done). Another difference was the presence of a peak at 
-1.o6v which decayed after about 2hrj the peak at -O.96V then 
appeared and in turn decayed with time. A peak also appeared at 
-O.36V early in the degradation of the 5 mg/ml solutions: the 
compound responsible for this peak degraded more slowly than 
the DKP 11. It disappeared completely after 22 hrsj and two small 
new peaks appeared at -O.22V and -O.84V after 54 hours. 
The presence of molecular oxygen and hydnogen sulphide in 
the degraded solutions was found to have an effect on the degradation 
of cephalexin. This is apparent from the modification observed in 
polarograms obtained in absence of hydrogen sulphide and dissolved 
molecular oxygen. When nitrogen gas was passed through the 
degrading solutions to blow off the hydrogcn sulphide, in addition 
to the hydrogen sulphide peak at -O.56V, the peaks at -O.78V 
(37°C and 80°C) and -O.16V (800 C) are lost also. When, however, 
the hydrogen sulphide was removed with air instead of nitrogen, 
the peak at -O.78V and -o.16v were present, indicating that these 
peaks are probably due to oxidation products produced by reaction 
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Fig. 12. D.p. polarogra",s of 2-hydroxy-3-phenyl-6-methylpyrazine 
in phosphate buffer solution pH 7.4. 
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Fig. 13. UV spec~rum obtained for 2-hydroxy-3-phenyl-6-methylpyrazine in distilled water. 
(i) pure sample, (ii) sample isolated after cephalexin hydrolysis 
of other degradation products with molecular oxygen in the solution. 
In Fig. 14 two polarograms obtained for the degradation of cephalexin 
in phosphate buffer (pH 7.4) at 37°C are compared: the first was' 
obtained for a solution from which the molecular oxygen and hydrogen 
sulphide had not been purged, and the second was obtained for a 
solution through which nitrogen gas had been passed during the 
degradation. 
A further effect of passing nitrogen through the degrading 
solution of cephalexin at 37°C W~q that the maximum transient 
yield of DKP 11 and the compound responsible for the peak at -1.2GV 
increased by about 35";6 and 25% respectively. At SOoC, however, 
the maximum yield of these compounds was increased by 25% and ~;6 
This is illustrated in Fig. 15A and 15B. 
In order to determine the amount of hydrogen sulphide evolved 
during the degradation of cephalexin, two techniques have been 
considered. At first, potentiometric titration of sodium sulphide 
formed after absorbing the hydrogen sulphide in lJfl sodium hydroxide 
solution against a standard solution of silver nitrate using a 
sulphide ion-selective electrode was tried. The method worked 
well for the determination of high concentrations of sulphide 
-4 (:>Ca 10 M), but at lower concentrations; the uncertainty in 
determining the end point has sO far precluded the use of this method. 
Nevertheless, the method was used infrequently to determine large 
amounts of· hydrogen sulphide evolved during the degradation, and 
also for the determination of the exact molarity of sodium sulphide 
solutions used later as a standard for the polarographic method. 
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Fig.14. Degradation of cephalexin at 37uC and pH 7.4. 
Upper polarograms: Molecular oxygen and hydrogen sUlphide removed with 
nitrogen. Time: (i) 22, (ii) 46, (Hi) 119 hours. 
Lower polarograms: Molecular oxygen and hydrogen sulphide not removed. 
Time: (i) 24.5, (ii) 46.5, (iii) 121 hours. 
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E(VOLT) vs. S.C.E. 
Fig. 15A. Degradation of 100 ~g/ml cephalexin in phosphate 
buffer at pH 7.4 at 800 G in the absence of molecular 
oxygen and hydrogen sulphide. Heasurer.1ent time: 
(i) 18; (ii) 32 and (iii) 148 min. 
Fig. 153. 
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E (VOLT) vs· se E 
Degradation of lOOJ.lg/ml cephalexin in phosphate buffer 
at pH 7.4 at 800 e in the presence of molecular oxygen 
and hydrogen sulphide. Measurement time: (i) 5. 
(ii) 35 and (iii) 160min. 
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Results obtained for standardization of about 0.111 sodium Bulphide 
solution against 0.1M silver. nitrate standard 1301 ution are shown 
in Table 4. 
Table 4. standardisation of about 0.1M sodiuM sulphide (lO.Oml) 
with 0.1M silver nitrate solution using a sulphide ion-
selective electrode. 
Volume of O. '111 Potential (mV) Volume of 0.111 Potential (mV) 
silver nitrate silo/er nitrate 
added (ml) added (ml) 
0.0 -867 17.7 -823 
2.0 -867 18.0 -820 
i~.O 
-865 18.2 -817 
6.0 -863 18.4 -812 
8.0 -856 18.5 -788 
10.0 -852 18.7 -761 
12.0 -848 18.9 -248 
14.0 -843 19.0 +15 
16.0 -835 19.2 +102 
17.0 .,.830 19.5 +119 
17.5 -826 20.0 +125 
From the plot of the potential (mV) versus the volume of silver 
nitrate, the end point was obtained at 19.1ml of O,lN silver 
nitrate. The molarity of sodium sulphide solution is 0.0955M. 
'fhe recovery of hydrogen sulphide, when it ,'as purged with 
nitrogen for or;e hour from a standard solution of sodium sulphide 
-4 0 (3.8 x 10 M) at pH 7.4 and 37 C and then absorbed in 50ml of lM 
sodium hydroxide, was determined by the potentiometric method. 
The results are shown in Table 5. 
Table 5. Potentiometric titration of sodium sulphiile formpd 
ae;ainst O.OlM silver nitrate standarJ solution. 
Volume of a.OlM Volume of O.OlH 
silver nitrate potential (r.tV) silver nitrate Potential (mV) 
added (ml) added (ml) 
0.0 -823 3.2 -752 
0.4 -821 3.4 -394 
0.8 -819 3.6 -143 
1.2 -816 3.8 -95 
1.6 -813 3.9 -77 
2.0 -809 4.0 -60 
2.4 -803 4.2 +72 
2.8 -793 
The end point was obtained at 3.6ml of O.OlM silver nitrate 
st.andard solution. The molarity of sodiu~ sulphide solution is 
3.6 x 10-411; it follows that the recovery of hydrogen sulphide is 
about 95%. 
Due to the unreliability of the potentiometric method to 
determine low concentrations of hydrogen sulphid", an attempt was 
made to use the d.p.p. peak of hydrogen sulphide at -0.56v, but the 
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reproducibility of the calibration curve obtained in this case was 
unsatisfactory. An indirect d.p.p. method was developed, however. 
In this method, the decrease in the cadmium peak height at -0.6W 
when it reacts with sulphide in citrate buffer solution (pH 4.6) 
was made the basis of a sensi.ti vs method for the determination of 
hydrogen sulphide. Typical d.p. polarograms obtained for cadmium 
after successive addition of sodium sulphide standard solution 
are shown in Fig. 16. A rectilinear calibration graph obtained 
over the concentration range 4.6 - 28 x lo5M is shot<n in Fig. 17.. 
This calibration graph has been used throughout this study to 
determine the amount of hydrogen sulphide evolved during the 
degradation of cephalexin and other cephalosporins studied. 
The results of degradation studies of cephalexin (lOO~g/ml) 
in phosphate buffer at pH 7.4 at 37.°C in which hydrogen sulphide 
was removed ,nth nitrogen and determined are depicted in Table 6A, 
6B and Fig. 18A, 18B. In Fig. 18A the fate of the sulphur during 
the degradation is shown. 
Table 6A. Amount of hydrogen sulphide evolved during cephalexin 
degradation at pH '7.1f and 37°'2. 
Time (hours) Amount of H~S Time (hours) Amount of H2S 
(Moles x 10 ) (Moles x 105 ) 
2.6 0.05 68.5 1.0 
5·5 0.10 76.5 1.02 
9.5 0.'15 93.5 1.17. 
22·5 0.40 102.0 1.20 
31.5 0·55 119.0 1.28 
46.0 0·7.5 142.0 1.36 
51.5 0.85 238.0 1 .'+ 
Table 6B. Results obtained for cephalexin degradation in phosphate 
buffer at pH 7.4 at 37°C in the absence of molecular 
oxygen and hydrogen sulphids 
'fL'lle (hours) Amount of D!?,' II Peak heichts ( )J A) 
(Holes x 10 ) at -1.26v 
1·5 0.4 0.0 
3·5 1.03 0.25 
5.25 1.46 0.35 
6.25 1.83 0.40 
7.0S 1.91+ 0.50 
7·1'5 2.07 0.70 
8.16 2.11 1.0 
8.66 2.10 1.0 
22.16 1.91 1.6 
30.16 1·59 2.2 
46.0 1.08 2.2 
51·5 0.93 2.3 
68.5 0.55 2.6 
76.5 0·53 2.8 
93·5 0.43 2.7 
102.0 0.38 2.7 
119.0 0.28 2.7 
142.0 0.14 2.6 
238.0 0.01 1.7 
After 2lRl hours DKP II had degrad"d completely and abo:.;t 50% 
of ,;ne total sulphur had been evolved as hydrogen sulphide. 
Apparently the remaining sulphur remains in the solution in an 
electroinactive form, possibly as the thiolactone identified by 
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Dinner92 ;supporting evidence for this thiolactone was provided 
by t.l.c. results which showed the same Rf values as those obtained 
by Bundgaard93 and Dinner92. In Fig. 18B, the height of the peak 
due to DKP 11 and the peak at -1.26v are compared throughout the 
degradation. A small peak appeared at -0.96v after about 140 hours 
indicating the formation of some 2-hydroxy-3-phenyl-6-methyl-
pyrazine. D.p. polarograms showing the formation of DKP 11 and 
its subsequent degradation at 37°C and pH 7.4 in the absence of 
hydrogen sulphide and molecular oxygen are shown in Fig. 19A and 
19B. 
The rate constant for the degradation of DKP 11 (37°C, pH 
7.4) based on the height of its polarographic peak changes after 
80 hours from 0.021 h-1 to 0.012 h-1• This is illustrated in 
Fig. 20. 
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Fie;. 16. D.p. polarograms obtained for cadmium in citrate 
buffer (pH 4.6) after successive syringe injections 
of sodium sulphide standard solution 
Sodium sulphide concentration (i) 0, (ii) 4.6, 
(iii) 9, (iv) 13, (v) 17, (vi) 21, (vii) 24.7 and 
(viii) 28 x lO-7M 
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Fig. 19. D.p. polarograms of the degradation of cephalexin showing 
the formation and degradation of the diketopiperazine 
derivative (11) at 37°C and pH 7.4 
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The effect of flushing with nitrogen on the degradation 
of cephalexin at Sooe and pH 7.4 was similar. Only three main 
peaks were observed (-0.9V, -0.96v and -1.26v). Production 
and degradation of DKP 11 was rapid. Comparison of pea~ currents 
is shown in Fig. 21A. Hydrogen sulphide production was rapid 
ini tially (25",0 recovery of total sulphur after 3 hours), but then 
slowed down considerably (see Fig. 21B). 
The effect of raising the pH of the degradation solution 
slightly was marked. Results obtained for 100~g/ml cephalexin 
solutions at pH S.5 (phosphate buffer) and Sooe are sho".m in 
Fig. 22A and 22B. A high proportion of the total sulph= (56%,7S%) 
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was elirr.inated as hydrogen sulphide within 6 hours and 29 hours Nespectively. 
Another significant change in the degradation pattern was the large 
increase in the yield of 2-hydroxy-3-phenyl-6-r:1ethylpyrs.zine. 
A small new peak at -1.08V appeared earl;,- in t.he degrac'3.tion but 
the compound x"esponsible had degraded completely after 2.1 hours. 
D.p. polarograms showing the formation of 2-hydroxy-3-p::enyl-6-
methylpyrazine in pH S.5 phosphate buffer and Sooe are ",",own in 
Fig. 23. 
The effect of pH on the degradation of cephalexin ."9.$ studied 
next. When the degradation was -::arried ont in phosphate buffer at 
pH 10 and Sooe, large peaks appeared at -1.08v "-n.d -1.2-';;-, after 45 
minutes, in addition to small peaks at -0.56v (hydroger: sulphide), 
-0.96v (2-hydroxy-3-phenyl-6-methylpyrazine) and -0.62"/ bnidentified 
peak). vlith increased heating time the peak at -1.08 c ecame smaller, 
whereas those at -O.62V, -0.96v and -1.26v increased. ~he hydrogen 
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showing the formation of 2-hydroxy-3-phenyl-6-
methylpyrazine. 
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sulphide was more difficult to purge in this case and incomplete 
removal of the gas was evident from the persistence of the peak 
at -0.56v in polarograms of the degraded solutions. However,.the 
amount of hydrogen sulphide (driven out with nitrogen gas and 
measured) within the first 5 hours was 10%. When the degradation 
was carried out under the same experimental conditions but in 
borate buffer solution at pH 10, the same polarographic pattern 
was obtained except that the peak at -1.26v disappeared and was 
replaced by a peak at -1.33V Fig. 24. 
Degradation was also studied in distilled water without 
buffering. The pH of the 100 ~g/ml cephalexin solution was 5.7. 
Hydrogen sulphide was obtained in relatively low yield at 800e 
(about 24% of the total sulphur after 30 hours). In addition to 
the DKP 11 peak at -0.9V, and 2-hydroxy-3-phenyl-6-methylpyrazine 
peak at -0.96v, peaks at -0.36v, -1.08v and -1.44V observed under 
other conditions were again observed. The DKP 11 peak at -0.9V 
was found to disappear after 4 hours, while the compound responsible 
for the peak at -1.08v degraded at a slower rate. The compounds 
responsible for peaks at -0.36v and -1.44V were major products in 
degradation at high concentration (10mg/ml). 
Degradation in citrate-phosphate buffer solution at pH 3 
and 800 e showed a similar polarographic pattern to that in 
unbuffered solution at pH 5.7, except that the peak at -l.08v 
was absent. The yield of DKP 11 and hydrogen sulphide after 4 
hours were only 8% and 5% respectively. 
160 
Fig. 24. 
L---1 
I 
... 
, ~ 
, I 
, 
, 
r , 
, 
I 
n 
( i j) 
,... 
I 
I 
I 
r 
I 
r 
r , 
1 I \ vI 
, 
, 
, 
, 
, 
\ (i) , v 
r , 
, , 
, 
, 
" , 
'I I , 
I ' , I , 
, , 
, , 
" 
I ' r I 
1 I 
1 , 
\ I 
I I 
\/ 
, 
I 
I 
I , 
I , 
, 
, 
, 
, 
, , 
', .... ' 
r 1 r 
-10 -1.2 -1·4 
E(VOLT) vs. S.C.E. 
, 
, 
, 
, 
" 
I 
I , 
, 
, 
/ 
Comparison of cephalexin degradation pattern at 
pH 10 and 80°C (i) phosphate buffer, (ii) borate 
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When the degradation of cephalexin was carried out in 0.01M 
sodium hydroxide solution at Z5°C, in addition to small peaks at 
-0.13V, -0.36v, -0.56v and -0.6zv, the peak of DKP 11 at -0.9V 
was observed which overlaps a peak at -0.8v later in the 
degradation. After 117 hours, when the degraded solution adjusted 
to pH 5 with citrate buffer and heated in a water bath for 20 
minutes at 100oC, a well defined peak at -0.96v due to 2-hydroxy-
3-phenyl-6-methylpyrazine was observed in addition to a very small 
peak at -0.56v. 
D.p. polarographic peaks appearing during the degradation of 
cephalexin are summarised in Table 7. 
An attempt Was made to prepare a sample of the compound responsible 
for the peak at -1.26"1 by heating a concentrated cephalexin solution 
(1g in 50ml phosphate buffer pH 7.4) at 80°C for 6 hours 
whilst flushing the solution with nitrogen. Hydrogen sulphide 
was taken out in 20ml of lM sodium hydroxide and its amount 
was determined by the potentiometric method previously discussed. The 
grey-white precipitate that formed was filtered off, washed with 
distilled water, dried in an oven at 50°C for 3 hours and then weighed. 
The identity of this compound, which was identified by Bundgaard93 
as 3-aminomethylene-6-phenyl-piperazine-2,5-dione IV, WaS confirmed 
by UV, IR and mass spectrometry. The product had the following 
characteristics: UV(water-ethanol 99: 1) , A 288nm, IR(kBr) V : 
maX maX 
3400-2900, 1700, 1640, 1595, 1510, 1450, 1350 and 1300 -1 , mle 219, cm 
important fragment ions, 217, 189, 188, 171, 132, 118, 112, 106, 
91, 85, 79, 77, 69, 63,57, 55, 51, 1+1 , 39, 30, 29, 16, 14. The 
° products had a melting point higher than 300 C. The yield of this 
compound and hydrogen sulphide was 57% and 58% respectively. No 
. 
Table 7. Differential pulse polarographic peaks appearing during 
the degradation of eephalexin 
Peak potential 
(V) 
-0.22 
-0.56 
-0.78 
-0.84 
-0.90 
-0.96 
-1.08 
-1.26 
-1.33 
-1.44 
Remarks about compound responsible 
Formed 1n low yield at 37°e and in relatively 
higher yield at 800 e in pH 7.4 buffer; oxidation 
product, not formed in absence of oxygen. 
Relatively minor product formed late in the degradation 
at high cephalexin level 
Major product formed early in distilled water at 
800 e (pH 5.7). Formed also in high yield at high 
cephalexin concentration in distilled water at 75°e. 
Hydrogen sulphide 
Oxidation product, not formed in absence of oxygen 
As for peak at -0.22V 
Diketopiperazine derivative (11): first major 
degradation product formed. 
2-hydroxy-3-phenyl-6-methylpyrazine(VI). Forms 
late in degradation usually but good yields obtained 
in pH 8.5 
High yield at pll 10 (80oe) degrades later 
High yield at 80oe(pH 7.4 and 8.5). 
Associated with appearance of peak at -1.o8v in 
borate buffer only at pH 10: seems to appear when 
peak at -1.26v is absent 
High yield at 
concentration 
800 e (pH 7.4), also at high cephalexin 
o (37 e) as the -1.26v peak is absent, 
and in unbuffered solution (pH 5.7). 
polarographic peaks were observed for this compound in phosphate 
buffer at pH 7.4. (Due to the extremely low solubility of this 
compound, it was first dissolved in dimethyl sulphoxide, then 
diluted with the buffer). Also, peaks were not observed for 
3-formy 1-3, 6-dihydro-6-pheny 1-2,5 ( 1H ,4}I) -pyrazi nedi one V whi ch is 
supposed to be formed after acid hydrolysis of compound IV (see 
Scheme 10). 
The filtrate obtained after removing compound IV showed 
polarographic peaks at -0.36v (0.25~A), -0.56v (0.2~A), -0.96v 
(0.7 ~A) and -1.26v (2.6 ~A). Attempts to extract the compound 
responsible for the peak at -1.26v using chloroform, isoamyl 
alcohol,ethyl acetate and methylene chloride at various pH values 
were unsuccessful. 
III 
oranic acid 
poranic acid 
HNl=f~ 
20 N-/CH,-R 
7-ACA R=OCOCH3 
7-ADCA R= H 
COOH . 
The degradation of these compounds has been studied in O.lM 
o 
sodium hydroxide solution at 25 C. The course of degradation was 
followed by d.p.p. and UV spectrophotometry. 
7-ADCA which contains an unsubstituted methyl group at the 
3-position is not reduced at the dropping mercury electrode, but 
some of its degradation products give polarographic peaks. Two 
polarographic peaks were observed in B.R. buffer at pH 2.4. The 
first peak at -O.22V formed later in the degradation, whereas the 
second major peak at -oJi2.,V formed rapidly after 7-ADCA degradation 
and attained its maximum value within two hours. The compound 
responsible for this peak degraded slowly with time. In Fig. 25 
the changes of peak currents with time are shown. D.p. polarogra~s 
showing part. of the degradation of 7-ADCA are shO\ffi in Fig. 26. 
When the degradation was followed by UV spectrophotometry, 
it was found that the UV absorption band at 265nm due to the intact 
7-ADCA disappeared after 110 minutes and a new absorption band at 
223nm appeared. The intensity of this band increased with time 
up to 95 hours. L~ss than 1% of the total sulphur of 7-ADCA was 
evolved as hydroge·n sulphide after If.5 hours. 
The degradation of 7-ACA appears to follow a different pathway. 
Marked differences in the polarographic and UV degradation patterns 
were observed in this case. The degradation of 7-ACA is more 
rapid than that of 7-ADCA. The degradation of 7-ACA indicated by the 
loss of the characteristic d.p. peak at -1.05V and the UV absorption 
band at 265nm was accompanied by ·the appearance of a new d.p. 
peak at -0.37V. This peak attains its maximum height within 90 
min and then degrades at a faster rate than the 7-ADCA degradation 
product responsible for the peak at -0.42V. Further, a small peak 
at -O.22V was observed after the compound responsible for the peak 
at -O.37V had degraded. D.p. polarograms showing part of the 
degradation of 7-ACA in sodium hydroxide solution are shown in 
Fig. 27. Peak currents of 7-ACA and its degradation products 
are shown in Fig. 28. 
UV absorption measurements showed that the absorption band of 
7-ACA had completely disappeared after 70 min degradation. 
This coincides with the disappearance of the 7-ACA d.p. peak 
at -1.05V. Also, an absorption band at 225nm which was observed 
in the early stages of degradation, was replaced by a more stable 
band at 24Dnm. 
The amount of sulphur evolved as hydrogen sulphide after 
4.5 hours was about 6% of the total sulphur present. 
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C. D.P. POLAROGRAPHIC DETERMINATION OF CEPHALEXIN AFTER HYDROLYSIS 
IN NEUTRAL PHOSPHATE BUFFER SOLUTION 
As was shown earlier, a high yield in solution of the compound 
responsible for the d.p. peak at -1.26V was obtained after cephalexin 
hydrolysis in phosphate buffer solution at pH 7.4 and 80oc. This 
peak has been made the basis of a sensitive and precise d.p. 
polarographic method for the determination of cephalexin. 
The method involves heating cephalexin in pH 7.4 phosphate 
buffer solution at 1000 C for 1 hour before recording the d.p. 
1 b t 1 1 and -1.4v at 25°C. po arograms e ween - • Typical d.p. polarograms 
obtained for cephalexin standards are shown in Fig. 29. The 
calibration graph obtained over the range 0.4 - 3 vg/ml of cephalexin 
in the measured solution was rectilinear and is shown in Fig. 30. 
The coefficient of variation (10 determinations) at the 2vg/ml 
level was 3.6%. Removal of dissolved oxygen from the solution 
before hydrolysing the cephalexin had no effect on the height 
of the peak obtained. 
The heating time waS found to affect the yield of the compound 
responsible for this peak, slightly, but negligible error occurs 
if the heating time is kept within 55 - 75 minutes. Peak heights 
obtained after 45 and 90 minutes heating were l~/o and 5% low 
respectively. No change in the peak height, however, was observed 
when the degraded solution was kept at 25°C for 2.5 hours. 
The degraded solution of cephalexin gave a positive test with 
2,4-dinitrophenylhydrazine indicating the presence of a carbonyl 
compound. Further, the peak at ~1.26v is decreased in steps On 
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the drop-wise addition of Schiff's reagent, and disappears 
completely on the addition of an excess amount of this reagent 
or of a few drops of 4~fo sodium bisulphite solution. The d.p. 
peaks of the other degradation products that are present, including 
2-hydroxy-3-phenyl-6-methylpyrazine, are unaffected by the 
addition of these reagents for carbonyl compounds. 
The nature of the polarographic wave at -1.26v was studied 
by d.c. polarography. Analysis of d.c. polarograms with respect to 
changes in the limiting current with height of the mercury, 
reservoir indicated that the wave is not fully diffusion controlled 
and probably has some kinetic character. This might be expected 
~f the carbonyl compound is an aldehyde. 
In the previous d.p.p. study of the degradation of cephalexin 
in pH 8.5 phosphate buffer at 80oc, 2-hydroxy-3-phenyl-6-methyl-
pyrazine Was shown to be formed at a constant rate during at least 
the first 30 hours (Fig. 21B). These conditions are clearly 
unsatisfactory as the basis for an analytical method. It was 
therefore assumed that the hydrolysis conditions optimised for 
the fluorimetric procedure62 would be optimum for the d.p.p. 
method too. Very unreliable results were obtained when that 
method was adopted for d.p.p. determination of cephalexin. At 
relatively high concentrations the precision on some occasions 
was good (i.e. coefficient of variation was abouv ~fo at the 
5~g/ml level) but on other occasions completely different peak 
heights were obtained. Attempts to improve the reliability and 
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precision by altering reagent concentrations and heating times and 
by adding formaldehyde as a catalyst were unsuccessful. 
A d.c. polarographic method for the determination of 
cephalexin based on hydrolysis in 5M hydrochloric acid solution 
o 28 
at 80 C for 15 minutes has been suggested by Squella et al • 
As the hydrolysis time is considerably shorter than that 
recommended above for hydrolysis in pH 7.4 buffer for 1 hour, this 
method was considered for adaptation at lower levels using 
differential pulse mode. 
The cephalexin levels used by Squella et al were very high 
(6 x 10-1K) and the d.c. currents obtained were disproportionately 
low. A non-rectilinear calibration graph over the concentration 
range 0 - 50 llg/ml was obtained in the present work using the 
conditions of Squella et aI, and the coefficient of variation was 
found to be very high (>8%). The d.p.p. peak was absent at 
cephalexin concentrations of less than 10 jlg/ml. Subsequently it 
was discovered that the height of the d.p.p. peak continued to 
increase rapidly for hydrolysis times up to at least 90 minutes. 
Even using these increased hydrolysis times the method was found 
to be highly irreproducible. 
A sample of 2,4-dinitrophenylhydrazone was obtained for the 
carbonyl compound responsible for the peak at -1.26v. The 
hydrazone derivative which purified on a preparative silica gel t.l.c. 
plate and obtained as a solid after extraction into ethanol had a 
melting point of;>318°c, and shows three UV absorption bands in 
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ethanol with A at 215, 255 and 385 nm. No further work has been 
max 
done to identify this compound. 
D. D.P. POLAROGRAPHIC STUDY OF THE DEGRADATION OF AMPICILLIN 
The initial degradation study was carried out at 37°e in pH 
7.4 phosphate buffer. Ampicillin itself gave no polarographic wave 
in the available potential range (0 - -1.6v) but after 1 hour an 
anodic Wave at -0.1V appeared and continued to increase in height 
after this. Hydrogen sulphide was found not to be formed during 
the degradation. 
The degradation pattern at pH 2.5 citrate-phosphate buffer 
was different. Two major peaks were obtained: an anodic peak at 
-0.14v and a cathodic peak at -0.64v. The first anodic peak was 
shown by comparison with polarograms of a known sample to be due 
to penicillamine. The peak disappears on addition of a few drops of 
0.1M silver nitrate,· also the addition of a few drops of 0.1M 
mercuric chloride results in the formation of a black precipitate 
possibly due to the formation of mercuric mercaptide of 
penicillamine. The second peak is due to 2-hydroxy-3-phenyl-6-
methylpyrazine. UV absorption spectrophotometric and t.l.c. 
studies confirm the formation of this latter compound. Degradation 
was studied at 37°e, 600 e and 80oe; the rate of degradation 
increases with temperature. The effect of dissolved oxygen was 
also studied ~nd it was found that the yield of penicillamine was 
considerably less in its presence. In the absence of oxygen 
the yields of penicillamine and 2-hydroxy-3-phenyl-6-methylpyrazine 
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(pH 2.5, sooe, 30 hours) were 20'~ and ~~ respectively. In addition 
to the peaks due to penicillamine and 2-hydroxy-3-phenyl-6-methyl-
pyrazine, an unidentified peak at -O.SV was observed in all 
degradation solutions at a later stage. In the presence of molecular 
oxygen, a further transient peak appeared at -0.45V (pH 2.5), 
the compound responsible for this peak apparently degrading rapidly 
itself. The peak at -O.SV was much larger in the presence of 
dissolved molecular oxygen. D.p. and d.c. polarograms of an 
ampicillin solution (lO~g/ml) after degradation at pH 2.5 and Sooe 
for 3.5 hours are shown in Fig. 31 and 32 respectively. 
Results obtained for the degradation of ampicillin in citrate-
phosphate buffer at pH 2.5 at 37°C, 60 0 e and Sooe are shown in 
Tables S - 10. In Fig. 33 and Fig. 34 the amounts of penicillamine 
and 2-hydroxy-3-phenyl-6-methylpyrazine formed during the degradation 
of 10mg of ampicillin trihydrate in 100ml of citrate-phosphate buffer 
at pH 2.5 and 600 c in the presence and absence of molecular oxygen 
are shown. D.p. peak heights of ampicillin degradation products 
obtained under the same experimental conditions are also compared in 
Fig. 35 and 36. 
Degradation of an ampicillin solution (10OWg/ml) at pH S.5 
again followed a different pattern. An anodic peak formed at 
-0.16v and this decreased in height again as a broad cathodic peak 
appeared at -1.16v. The anodic peak is thought to be due to a thiol 
compound formed from the opening of the thiazolidine ring, and the 
peak at -1.16v to be due to a carbonyl compound formed as this thiol 
is hydrolysed. Typical d.p. polarograms are shown in Fig. 37. 
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The polarographic behaviour of penicillamine was investigated 
using a pure sample. The anodic polarographic wave was shown to be 
diffusion controlled by mercury height and temperature studies 
1 
(1... vs h2 gives a straight line passing through the origin and 
Urn 
a temperature coefficient of 0.8% deg-1 was obtained). 
The effect of pH on penicillamine d.p. peak potential, peak 
current, and d.c. wave height is shown in Fig. 38. The peak 
potential varied rectilinearly over the pH range 2-8 (Ep =-0.03 -
0.059 pH V). The d.p. peak current is more dependent upon the 
pH than the d.c. wave height. 
Typical d.p. polarograms obtained for the determination of 
penicillamine in citrate-phosphate buffer solutions at pH 2.5 
o 
and 25 C are shown in Fig. 39. Rectilinear calibration graphs 
were obtained over the concentration ranges of 1.96 - 21.8~gjml 
and 9 - 44.4 ~g/ml. The degradation of perncillamine in the 
presence of molecular oxygen in citrate-phosphate buffer solution 
at pH 2.5 and 600 c is shown in Fig. 40: the broad peak which 
appears at -1.0V is thought to be due to a carbonyl compound. 
The polarographic behaviour of 2-hydroxy-3-phenyl-6-methylpyrazine 
was also studied using a pure sample. The cathodic polarographic 
wave Was "shown to be diffusion controlled by mercury height and 
temperature studies (temperature coefficient in this case is 0.4% 
-1 ) deg • The effect of pH On peak potential and peak current is 
shown in Fig. 41, from which it can be seen that the peak potential 
varies rectilinearly over the pH range 2 - 9 (Ep = -0.49 - 0.067 pH V). 
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The peak current is highly dependent on pH having a maximum value 
at pH 3: the peak height decreased to almost zero at pH 11. D.p. 
polarograms of 2-hydroxy-3-phenyl-6-methylpyrazine in citrate-
phosphate buffer solution (pH 2.5) are shown in Fig. 42. 
Rectilinear calibration graphs were obtained over the ranges 1.74 -
8.4 \lg/ml and 1.9 - 11.4 \lg/ml. 
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-1 (Natural drop time, SCan rate 1 mVs I low pass filter 3) 
~able 8. 
Time/hr 
0.5 
1.5 
4.25 
19.50 
22.8 
26.2 
45.7 
89.8 
97.2 
Data obtained for the degradation of ampicillin (2.45 x 10-5Moles) in citrate-
phosphate buffer solution at pH 2.5 and 37°C in presence of molecular oxygen 
Penicillamine 2-hydroxy-7-phenyl-6-methylpyrazine Peak at -0.45V 
I (\lA) Amount (Molxl07) I (\lA) Amount (Mol x 107) Ip (\lA) p p 
0.0 0.0 0.0 0.0 0.0 
0.0 0.0 0.0 0.0 0.0 
0.0 0.0 0.0 0;-0 0.0 
0.55 1.5 0.55 0.46 0.3 
0.80 2.7 1.10 0.86 1.3 
0.95 3.4 1.30 1.0 0.0 
1.90 7.8 3.80 2.8 0.0 
2.50 10.5 8.60 6.98 0.0 
2.70 11.5 9.55 7.8 0.0 
Peak at -0.8v 
I (\lA) p 
0.0 
0.0 
0.0 
0.02 
0.05 
0.05 
0.25 
0.60 
0.75 
~---------------------------------------------------------- -
Table 9. Data obtained for the de radation of am icillin (2.45 x 10-5Moles) in citrate- hosphate 
buffer at pH 2.5 and 0 C in absence of molecular oxygen 
Time/min Penicillamine 2-hydroxy-3-phenyl-6-methylpyrazine Peak at Absorbance 
Ip (!lA) Amount(Molexl07 ) Ip ( !lA) Amount(Molexl07) -0.8v 350nm 11) (]lA) 
12.0 0.0 0.0 0.0 0.0 0.0 0.0 
30.0 0.45 1.1 0.2 0.2 0.0 0.0 
44.0 1.70 6.8 2.0 1 .51 0.15 0.24 
66.0 3·0 12.8 4.4 3.25 0.20 0.43 
85.0 3·95 17.2 6.1 4.49 0.20 0.62 
139.0 10.1 -35.3 11.4 9.37 0·30 1.04 
191.0 12.8 44.8 13.7 11·30 0.30 1.30 
376.0 14.9 52.1 16.3 13.48 0·30 1.64 
at 
Table 10. 
(A) 
Time/hr 
0.42 
1.22 
2.0 
6.66 
9.16 
23.8 
30.4 
Data obtained for the de radation of am icillin (2.45 x 10-5Moles) 
buffer solution atpH 2.5 and 0 C 
(A) In presence of molecular oxygen 
( B) In absence of molecular oxygen 
Penicillamine 2-hydroxy-3-phenyl-6-methylpyrazine 
Ip (\lA) Amount (Mole x 107) I (\lA) Amouni;{Mole :i 107) P 
0.0 0.0 0.0 0.0 
0.1 0.6 0.05 0.1 
1.0 3.6 1.05 0.82 
2.9 12.4 5·30 3.9 
3.5 15.2 8.00 6.5 
2.6 11.0 15.30 12.7 
2.0 8.2 16.30 13.5 
Peak at -0.8v 
Ip (\lA) 
0.0 
0.0 
0.15 
0.25 
0.40 
1.0 
1.2 
Table 10(8). 
Penicillamine 2-hydroxy-3-phenyl-6-methylpyrazine Peak at -0.8v 
Time/hr I p (\lA) Amount (Mole x 10
7) Ip (\lA) Amount(M61e x 107) Ip (\lA) 
0.42 0.0 0.0 0.0 0.0 0.0 
1.22 0.1 0.6 0.05 0.1 0.0 
2.0 1.1 4.1 1.30 1.0 0.05 
6.66 4.4 19·3 5.7 4.2 0.10 
9.16 6.8 23.7 8.6 7.0 0.15 
23.8 13·7 47.9 15.2 12.56 0.15 
30.4 13.8 48.3 16.0 13.24 0.20 
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GENERAL DISCUSSION 
Previous workers22,23,28have studied the determination of some 
cephalosporins by d.c. polarography and cathode-ray polarography. 
Ochiai et al25 indicated that cephalosporins with a substituted 
methyl group at the 3-position of the dihydrothiazine ring are 
reduced at the dropping mercury electrode at about -1.2V. 
Thus cephalospori1s with an unsubstituted 3-methyl group are not 
reduced at the d.m.e. in the available potential range. Some 
cephalosporins have reducible groups elsewhere in the molecule 
and give polarographic waves at less negative potentials. The 
present work was carried out to investigate any advantages that 
d.p.p. might have "for the determination of cephalosporins and their 
degradation products. 
Cephalosporins"having a sUbstituted methyl group at the 
3-position have been determined down to 0.1 ~g/ml level using the 
d.p.p. peaks at -1V despite the peaks being near the cathodic 
" limits under the conditions used. This is illustrated by the 
results obtained for cephalothin, cephaloridine, 7-aminocephalorporanic 
acid, deacetylcephalosporin C and cephoxazole contained in Table 1 
and by the d.p. polarograms shown in the Appendix. Other 
cephalosporins which contain other reducible groups elsewhere in 
the molecule in addition to the substituted methyl group at the 
3-position, however, give other d.p. peaks at less negative 
potentials. For example, cephalonium and cefuroxime showed three 
and two polarographic peaks respectively. The sensitivity of the 
d.p.p. method is superior to that of d.c. and cathode-ray polarography 
reported previously by other workers22 ,23 and could replace the 
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chemical and spectrophotometric methods currently in use. Also, 
the method can function as a possible check on a microbiological 
assay particularly when a mixture of two or more dissimilar 
antibiotics has to be analysed. Without prior separation of the 
antibiotics, such an analysis would be impossible by the 
microbiological technique. Further, it was shown using cephalothin 
and cephaloridine that d.p.p. is a useful technique for following 
the degradation of such cephalosporins. Degradation can be followed 
directly ina polarographic cell with no interference from 
degradation products. It should be noted that the degradation 
reaction was followed using the decrease in the d.p. peak at -IV; 
the decrease in the height of this peak arises specifically owing 
to the hydrolytic elimination of the 3-methyl substituent. 
Although cephalosporins which do not have a substituted 
3-inethyl group, and have no. other reducible groups, do not give 
d.p. reduction peaks themselves, many of their degradation prodUcts 
do. The cephalosporins studied in this category were cephalexin, 
cephradine and 7-aminodeacetoxycephalosporanic acid <7-ADCA). 
However, the present studies have been concentrated on cephalexin. 
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The kinetics and mechanisms of the degradation of cephalexin 
have been previously studied extensively by other workers81 - 84 ,91-93. 
As the cephalexin molecule contains an a-amino group in the 
7-position, it undergoes intramolecular aminolysis on degradation, 
producing a diketopiperazine derivative which is unstable itself 
and undergoes further degradation. The degradation pathway of 
cephalexin has been discussed earlier in this thesis. 
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The main finding of this work is that several cephalexin 
degradation products are polarographically active. Hydrogen sulphide 
has been shown to be eliminated during the degradation. Also the 
kinetics and mechanisms of the degradation reactions are critically 
dependent upon the experimental conditions under which the 
degradation is carried out. 
The initial degradation product of cephalexin, the diketopiperazine 
derivative, was isolated from a degraded solution of cephalexin, 
and a d.p.p. procedure for its determination has been developed. 
The procedure has been applied to the determination of the 
diketopiperazine during the degradation. Also, 2-hydroxy-3-phenyl-
6-methylpyrazine, which was isolated from degraded solutions of 
a -aminobenzylcephalosporins and a -aminobenzylpenicillins under 
" 1 "t 1 d" t" 66 f d t b d d" d speC1a exper1men a con 1 lons was oun 0 e pro uce 1n a goo 
yield under the conditions used in this study. 
The present work appears to be the first to report the formation 
of hydrogen sulphide in the degradation of cephalexin and 
cephradine, although its odour is apparent in deteriorating 
sample solutions. Hydrogen sulphide has been found to give a reduction 
peak at -O.56V. The peak arises owing to formation of mercury(II) 
sulphide at the surface of the mercury drop which is subsequently 
reduced to mercury and sulphide. 
HgS + H+ + 2e 
The peak has also bee~ observed in the cathodic stripping analysis 
of hydrogen sulphide95 • Youssefi et a196 used this d.p. peak for 
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the direct determination of sulphide. When this method was applied 
here for the determination of hydrogen sulphide, the linearity 
of the analytical plot and the precision were found to be unsatisfactory. 
An indirect d.p.p. method, however, has been developed for the 
determination of sulphide On the basis of the decrease in the 
cadmium d.p. peak when it reacts with sulphide. 
In an attempt to identify positively the hydrogen sulphide 
evolved during cephalexin degradation, a mass spectrum was taken 
on a sample of the gas evolved. The m/e peak at 34 (H2S) was present 
but the highest peak was at 74; the compound responsible was not 
identified. That no mercaptans were evolved and absorbed with 
the hydrogen sulphide in the trapping solution, however, was shown 
by the analytical results. Mercaptans do not react with cadmium 
nitrate solution97 , and the polarographic method we applied determines 
the hydrogen sulphide only. Furthermore, the initial potential of 
the lM sodium hydroxide solution after trapping the gas is 
consistent with the gas being hydrogen sulphide. Any mercaptan 
present would have given a second end point at about-500mV and this 
was not observed97 • 
A pronounced effect on the kinetics and meChanisms of the 
degradation of cephalexin was noticed when the experimental conditions 
of the degradation were varied. Spme degradation products were found 
to be produced only in the presence of molecular oxygen. Other 
degradation products were formed only at high initial concentrations 
of cephalexin. Also the pH of the degradation solution was found 
to affect the yield and the identity of the degradation products. 
Cephradine has been found to behave similarly to cephalexin 
except that the rate of degradation is much faster than that of 
cephalexin. This increase in the reactivity of cephradine must be 
attributed to the presence of the 1,4-cyclohexadienyl group in the 
7-position which may facilitate the intramolecular nucleophilic 
attack of the side chain CL -amino group on the carbonyl carbon atom 
of the S -lactam ring. The degradation of the diketopiperazine 
derivatives of cephalexin and cephradine were found to follow a 
first order reaction with rate constants of 0.025 and 0.03 h-1 
respectively. Between 70 and 80 hours the values of the rate constants 
were found to increase rapidly then attain their original values. 
However, in the absence of hydrogen sulphide and molecular oxygen, 
the degradation of DKP 11 was slightly slower. A first order rate 
constant of 0.021 h -1 was obtained: again an abrupt change in the 
rate constant to 0.012 was observed after 80 hours degradation, but 
in this case the new value of the rate constant did not change 
(see Fig. 9 and 20). This phenomenon has not been satisfactorily 
explai,ned so far. 
At pH 7.4 and 37°C the amount of hydrogen sulphide evolved 
during cephalexin degradation was about 50% of the total sulphur 
present. About ~/o of the total sulphur was produced in the first 
80 hours, and then the production of hydrogen sulphide was reduced 
considerably (see Fig. 18A). These results coincide with the abrupt 
change in the rate constant of the degradation of DKP 11 after 80 
hours, and may indicate that the degradation of DKP 11 follows a 
different mechanism, i.e. after 80 hours DKP 11 does not degrade via 
the thiolactone Ill. It is suspected that the degradation of this 
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lactone gives hydrogen sulphide and the carbonyl compound responsible 
for the d.p. peak at -1.26v. However, this suggestion needs confirmation 
by studying the degradation of a pure sample of the thiolactone III 
under the same experimental conditions. 
Previous methods for the quantitative determination of cephalexin, 
cephradine and cephaloglycine include UV spectrophotometry, iodometric 
th d d h dr 1 ° d tOtO 20,21 me 0, an y oxy am~ne . e erm~na ~ons • These methods, 
however, lack sensitivity and selectivity. A sensitive fluorimetric 
60 procedure for the determination of these compounds was recently 
developed but again the selectivity is poor as the method is applicable 
to all a-aminobenzylcephalosporins and a-aminobenzylpenicillins. 
Benner23 developed a cathode-ray polarographic method for the 
determination of cephalexin following alkaline hydrolysis. Recently, 
Squella et a128 described a d.c. polarographic method for the 
determination of cephalexin at high concentrations. 
In the present work, .a d.p. polarographic method of the 
determination of cephalexin has been investigated, and a procedure 
based on the formation of a d.p.p. peak at -1.26v following cephalexin 
hydrolysis was recommended for general use. This procedure is superior 
to two other d.p.p. procedures, based on hydrolysis to 2-hydroxy-
3-phenyl-6-methylpyrazine and on hydrolysis in 5M hydrochloric acid. 
The sensitivity and precision of the recommended procedure is good. 
The initial diketopiperazine derivative formed, however, if present 
in the ce·phalexin sample, would produce the peak at -1.26v and would 
interfere. The presence of this compound, however, can be tested for 
by polarographing the solution before the hydrolysis step, as it 
gives a d.p.p. peak at -O.9V. (pH 7.4) and its concentration could 
be determined and allowed for. It is envisaged, therefore, that as 
well as for determination of low concentrations of cephalexin in a 
degradation-free .system, the d.p. polarographic method could be used 
with advantage·in degradation and metabolic stUdies. 
When the degradations of 7-ACA and 7-ADCA were studied in 0.1M 
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sodium hydroxide, and the course of degradation was followed by d.p.p. 
and UV spectrophotometry, it was noticed that the rate of degradation 
of 7-ACA (as indicated by the decrease in the d.p. peak at -1.05V 
and by UV spectra) was much faster than that of 7-ADCA (as indicated 
by the increase of the peak of the degradation product at -0.42V 
and by UV spectra). This increase in the degradation rate of 7-ACA 
must be attributed to the presence of the acetoxY group in the 
3-position of 7-ACA. Previous workers42 ,98 indicated that the 
reactivity of the ~ -lactam ring is enhanced as the electronegativity 
of the 3-methyl substituent increased. 
In addition to the difference in the degradation rates of 7-ACA 
and 7-ADCA, marked differences in the polarographic patterns and UV 
absorption spectra of degraded solutions of 7-ACA and 7-ADCA.were 
observed. Degraded solutions of 7-ACA show an absorption band at 
225nm and the compound responsible for this band degraded later and 
a new stable absorption band at 240nm was observed. The first 
product may be an unstable intermediate and the second product may 
correspond to a more stable penaldate degradation product similar to 
that obtained following 7-n-butyramidocephalosporanic acid degradation 
Degraded solutions of 7-ADCA, on the other hand, do not show 
an absorption band at 240nm, but at 223nm. The compound responsible 
seems to be stable since an increase in the-intensity of this band 
was observed with time. Again, this stable compound may correspond 
to the'cephalosporoate derivative suggested by Hamilton-Miller et al 
76,77 (see Scheme 8). 
The amount of sulphur evolved after 4.5 hours degradation as 
hydrogen sulphide from 7-ACA and 7-ADCA represented about 6% and 
~l% of the total sulphur present respectively. This is consistent 
with the fragmentation of the molecule in the first case only to 
form the proposed penaldate. More work is certainly required in 
order to positively identify these degradation products. 
In contrast to the corresponding Cl -aminobenzylcephalosporin. , 
cephalexin, the Cl -aminobenzylpenicillin, ampicillin, does not give 
hydrogen sulphide on degradation at pH 2.5 and 7.4. Analogous 
compound to diketopiperazine 11 derivative which might be expected 
to be formed from ampicillin has not been observed. This compound 
would be expected to give a d.p. peak near -0.9V (pH 7.4) as does 
DKPII. Instead in the degradation of ampicillin, penicillamine 
and 2-hydroxy-3-ph,,:pyl-6-methylpyrazine are formed at low pH (pH 2.5). 
The polarographic behaviour of these products has been investigated,' 
and d.p.p. procedures for their determination have been developed. 
The amounts of penicillamine and 2-hydroxy-3-phenyl-6-methylpyrazine 
formed indicated that the yield obtained in pH 2.5 buffer at 800 c 
after 30 hours in the absence of oxygen is 2Cffo and ~fo respectively. 
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Therefore, other polarographically inactive species must also be 
formed including the various· polymeric species investigated by 
Kuchinskas and Levy99 and Stanfield et 1100 a • 
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CONCLUSION 
The present work on the degradation of cephalosporins and 
ampicillin illustrates well the potentialities of d.p.p. in 
degradation and stability testing studies of pharmaceuticals. 
Considerable information has been obtained using d.p.p. which would 
have been difficult to obtain by other methods, in addition to 
information that has confirmed previous work by other investigators 
using other methods. D.p. polarography seems to be ideally suited 
for kinetic studies of cephalosporins and penicillins. The sensitivity 
of the technique has allowed kinetic measurements to be made 
at low concentration levels and to measure simultaneously the 
concentration change for more than one electroactive species of 
the degradation solution. D.p.p. measurements have enabled us 
in some cases to detect degradation intermediates and also provided 
valuable information about the optimum conditions for their preparation. 
D.p.p. seems to be competitive with other methods which are 
usually used to study the degradation kinetics of S -lactam 
antibiotics. These latter methods which depend upon measurements 
of the change in the amount of the intact drug compound or, 
alternatively, on determining the amount of degradation product, 
either biologically or chemically, lack selectivity and sensitivity 
and are time consuming. Recently, HPLC with UV detection has been 
used increasingly for following degradation reaction in aqueous 
solutions. A possible problem which may arise with the use of HPLC 
is that compounds that degrade rapidly in aqueous solutions may 
possibly degrade further, more rapidly, and possibly by a different 
mechanism, during their passage through an HPLC column. 
APPENDICES 
Typical d.p. polarograms obtained for the cephalosporins 
studied at the optimum pH are shown, together with graphs showing 
the effect of pH on the peak potentials (full lines) and peak 
heights (broken lines). 
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APPENDIX 2 
Further Comments on Ampicillin Degradation 
After 'this work had been completed, LeBelle et al65 
reported the isolation of a fluorescent product following ampicillin 
degradation. The isolated product was found by unambiguous synthesis 
and by other analytical techniques to be 2-hydroxy-3-phenylpyrazine. 
The experimental conditions under which this compound was isolated 
was slightly different from those of Barbhaiya et al66 in which 
2~hydroxy-3-phenyl-6-methylpyrazine was obtained. The present 
additional study was made in order to see whether this new fluorescent 
product has the same polarographic and UV absorption characteristics 
as those of 2-hydroxy-3-phenyl-6-methylpyrazine or not. 
In this work the degradation of ampicillin was followed by 
d.p.p. and UV spectrophotometry under exactly the same experimental 
conditions as LeBelle et aI, i.e. hydrolysis of ampicillin (50mg/ml) 
at pH 11-12 for 2 hours at room temperature, followed by hydrolysis 
. 0 
at pH 2 and 50 C for 5 hours. The characteristic d.p.p. peaks of 
penicillamine and 2-hydroxy-3-phenyl-6-methylpyrazine were again 
observed but the UV spectrum of the degraded solution was found 
to be modified. In addition to the broad absorption band at about 
260nm, an absorption band with A 330nm which overlaps another 
max ' 
weaker band at 350nm was observed. A spectrum of a pure sample 
of 2-hydroxY-3-Phenyl-6-~ethylpyrazine or of a degraded solution of 
ampicillin in citrate-phosphate buffer at pH 2.5 shows two well defined 
absorption bands at 250nm and 350nm (Fig. 1). LeBelle et al 
speculated that the different product obtained by Barbhaiya et al66 
is due to the use of formaldehyde as a catalyst (in the latter case) 
which is incorporated into the final reaction product, but we have 
shown earlier that 2-hydroxy-3-phenyl-6-methylpyrazine can be 
formed in the absence of formaldehyde and under different conditions 
of those of Barbhaiya et al. It seems to be that under the 
221 
experimental conditions of Le Belle et al both 2-hydroxy-3-phenylpyrazine 
and 2-hydroxy-3-phenyl-6-methylpyrazine is formed and these two 
compounds are indistinguishable by d.p.p. Jusko53 reported that 
at low ampicillin concentrations only one fluorescent degradation 
product was detected, while at higher concentrations several fluorescent 
products were obtained. No more work has been made in this direction 
and further investigations need to be carried out to shed more light 
on the mechanisms by which these fluorescent degradation products 
are formed. 
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